Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Translating bone cell biology into clinical practice: target identified as RANK ligand

      ea0022eje1
    • European Journal of Endocrinology Prize Winner

      ea0022eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Transgenes and physiology in the Growth Hormone axis: a view from the portal

      ea0022gh1
    • Geoffrey Harris Prize Winner

      ea0022gh1biog
• Plenary Lectures
• • Twenty years' experience with post-Chernobyl thyroid cancer
  • • Twenty years experience with post-Chernobyl thyroid cancer

      ea0022pl1
  • Testicular dysgenesis and endocrine disruptors
  • • Testicular dysgenesis and endocrine disrupters

      ea0022pl2
  • Hypothalamic regulation of gonadotrophin secretion
  • • Novel regulator of gonadotropin

      ea0022pl3
  • Thyronamines: beyond T4 and T3
  • • Thyronamines: beyond T4 and T3

      ea0022pl4
  • Discovery and relevance of the incretin system
  • • Discovery and relevance of the incretin system

      ea0022pl5
  • Sex and SOX
  • • Sex and SOX

      ea0022pl6
  • New trends in diagnosis and localisation of (neuro) endocrine tumours
  • • New trends in diagnosis and localization of (neuro)endocrine tumors

      ea0022pl7
  • An update on the genetics of obesity
  • • An update on the genetics of obesity

      ea0022pl8
• Symposia
• • European networks
  • • Endocrinology of the aging male: the European Male Ageing Study (EMAS)

      ea0022s1.1
    • NECTAR: network for environmental chemical toxicants affecting reproduction

      ea0022s1.2
    • EUGOGO

      ea0022s1.3
    • The EuroDSD project and consortium

      ea0022s1.4
    • EurAdrenal

      ea0022s1.5
    • The European Registry on Cushing's syndrome (ERCUSYN) database: first year experience

      ea0022s1.6
  • Endocrine aspects about the metabolic syndrome
  • • Brain-adipose and brain-liver connections in the metabolic syndrome

      ea0022s2.1
    • Combined GH and IGF1 therapy

      ea0022s2.2
    • Unacylated ghrelin: a metabolic hormone

      ea0022s2.3
    • Testosterone treatment in the metabolic syndrome

      ea0022s2.4
  • Bone cell biology
  • • Skeletal stem cells and mechanisms of bone formation

      ea0022s3.1
    • Cross talks between leptin and the skeleton

      ea0022s3.2
    • The role of the hypothalamic-pituitary-thyroid axis in bone

      ea0022s3.3
  • The aging male
  • • Genetic aspects of ageing in men

      ea0022s4.1
    • Osteoporosis in the aging male

      ea0022s4.2
    • The natural history of symptomatic androgen deficiency in men: longitudinal results from the Massachusetts Male Aging Study

      ea0022s4.3
  • Novel targets for thyroid cancer treatment
  • • Novel targets for thyroid cancer treatment

      ea0022s5.1
    • Molecular mechanisms in thyroid cancer

      ea0022s5.2
    • Tyrosine kinase inhibitors in thyroid cancer

      ea0022s5.3
  • Neuroendocrine control of reproduction
  • • Sexual differentiation of hypothalamic Kiss1 neurons

      ea0022s6.1
    • KNDy (kisspeptin/neurokinin B/dynorphin) cells of the arcuate nucleus: a central node in the control of GnRH secretion

      ea0022s6.2
    • Consequences of non-classical ER[alpha] signaling in brain

      ea0022s6.3
    • Insulin regulation of reproductive brain: rodent and human studies

      ea0022s6.4
  • Approaches to preservation of gonadal function after cancer therapy
  • • Ovarian transplantation

      ea0022s7.1
    • ART/IVF and cryopreservation

      ea0022s7.2
    • Oocyte cryopreservation

      ea0022s7.3
  • Endocrine tumours: new genes and association with syndromes
  • • Pituitary adenoma predisposition caused by AIP germline mutations

      ea0022s8.1
    • New multiple endocrine neoplasias: endocrine tumors associated with gastrointestinal stromal tumors (GISTs)

      ea0022s8.2
    • Update on familial pituitary tumors: from multiple endocrine neoplasia type I to familial isolated pituitary adenomas

      ea0022s8.3
  • The role of oxidative stress in the development of the metabolic syndrome
  • • Mitochondrial dysfunction and insulin resistance

      ea0022s9.1
    • Macrophage dysfunction and insulin resistance

      ea0022s9.2
    • Marked improvement of insulin resistance by reduced age intake; a non-pharmacologic, non-nutrient based intervention for type 2 diabetes

      ea0022s9.3
  • Novel aspects in the treatment of bone disease
  • • Principles of bone biology (the major pathways, RANKL, SOST, Wnt etc)

      ea0022s10.1
    • Preclinical and clinical effects of RANK ligand inhibition

      ea0022s10.2
    • Teriparatide and parathyroid hormone in the treatment of ostoporosis

      ea0022s10.3
  • Premature ovarian failure
  • • A pivotal role for NR5A1 in human reproductive processes

      ea0022s11.1
    • Premature ovarian failure due to overactivation of primordial follicles in mice

      ea0022s11.2
    • Ovarian AMH: implications for the diagnosis of premature ovarian failure

      ea0022s11.3
    • Genetic defects in ovarian growth/differentiation factors

      ea0022s11.4
  • Thyroid hormone metabolism and action: new developments
  • • Thyroid hormone transporters

      ea0022s12.1
    • Life without T4 to T3 conversion

      ea0022s12.2
    • Thyroid hormone signalling in the heart

      ea0022s12.3
    • Significance of thyroid hormone receptor [alpha] in metabolism

      ea0022s12.4
  • The TSH reference range
  • • Determinants of the TSH reference range

      ea0022s13.1
    • Health outcomes related to TSH values within the reference range

      ea0022s13.2
    • A critical synopsis of meta-analysis in the field of subclinical thyroid disease

      ea0022s13.3
    • Solving the dilemma: what to do as a simple clinician

      ea0022s13.4
  • Novel actions of vitamin D
  • • Vitamin D and diabetes

      ea0022s14.1
    • Vitamin D and Wnt signalling in colon cancer

      ea0022s14.2
    • Vitamin D dependent anti-microbial pathways

      ea0022s14.3
    • Vitamin D and differentiation of mesenchymal stem cells and osteoblasts

      ea0022s14.4
  • Wnt signalling
  • • Wnt/[beta]-catenin controls stem cells in regeneration and tumor formation

      ea0022s15.1
    • Wnt-signaling and the metabolic syndrome

      ea0022s15.2
    • Adipogenesis, diabetes and wnt signalling

      ea0022s15.3
  • Hot topics in pituitary disease
  • • Pros and cons of large scale screening of Cushing's syndrome

      ea0022s16.1
    • The safety of dopamine agonists: clinical perspectives

      ea0022s16.2
    • Problems with GH and IGF1 assays: progress?

      ea0022s16.3
  • Genetic basis of infertility: clinical studies and clinical models
  • • Genetically modified mouse models for the analysis of reproductive disorders

      ea0022s17.1
    • Neurokinin B signaling in human puberty

      ea0022s17.2
    • Genetics of Kallmann syndrome

      ea0022s17.3
  • Diabetes in pregnancy
  • • Progress towards new criteria for diagnosis and classification of glucose metabolism during pregnancy

      ea0022s18.1
    • New treatment modalities in diabetic pregnancy

      ea0022s18.2
    • Gestational diabetes: high risk for future diabetes and cardiovascular disease

      ea0022s18.3
  • Fetal microchimerism as an explanation of disease
  • • Microchimerism: introduction and animal models

      ea0022s19.1
    • Molecular microchimerism detection: its importance for non-invasive prenatal diagnosis and preeclampsia

      ea0022s19.2
    • The role of microchimerism in autoimmune diseases

      ea0022s19.3
  • The endocrine incidentaloma
  • • The endocrine incidentaloma

      ea0022s20.1
    • Pituitary incidentalomas

      ea0022s20.2
    • Adrenal incidentalomas

      ea0022s20.3
  • The cardiometabolic interface
  • • Endothelial dysfunction in type 2 diabetes

      ea0022s21.1
    • Role of PPAR signalling in diabetic dyslipidemia

      ea0022s21.2
    • Mechanisms and treatment of diabetic dyslipidemia

      ea0022s21.3
  • MicroRNAs in endocrinology
  • • MicroRNAs in biology

      ea0022s22.1
    • MicroRNAs in thyroid cancer

      ea0022s22.2
    • The role of miRNAs in hormone signaling

      ea0022s22.3
  • Obesity: clinical manifestations and therapeutic intervention
  • • Obesity: clinical manifestations and therapeutic: does the choice of diet make any difference?

      ea0022s23.1
    • Lifestyle intervention and pharmacological approaches to weight loss

      ea0022s23.2
    • Hormonal changes after bariatric surgery

      ea0022s23.3
  • Diagnosis and treatment of endocrine malignancies
  • • Malignant pheochromocytomas or paragangliomas

      ea0022s24.1
    • Diagnosis and treatment of adrenocortical carcinomas

      ea0022s24.2
    • Parathyroid carcinoma

      ea0022s24.3
  • Non-classical responses to hormones
  • • Rapid androgen action in epithelial and stromal cells

      ea0022s25.1
    • Non-classical actions of estrogens in endocrine pancreas

      ea0022s25.2
    • Protein kinase D as a modulator of aldosterone action in the kidney

      ea0022s25.3
    • Extranuclear effects of thyroid hormones

      ea0022s25.4
  • Adverse effects of drugs on thyroid
  • • Tyrosine kinase inhibitors and thyroid

      ea0022s26.1
    • Treatment of amiodarone-induced thyrotoxicosis (AIT) type 2: a RCT

      ea0022s26.2
    • Interferons and the thyroid

      ea0022s26.3
  • Multifaceted aspects of neuroprotection
  • • Relationship between oestrogen and cholesterol in neuroprotection

      ea0022s27.1
    • Relationship between oestrogen and cholesterol in neuroprotection

      ea0022s27.2
    • Progesterone and the nervous system

      ea0022s27.3
    • Oestrogen and corticotrophin releasing hormone: two hormones with different targets in neuroprotection

      ea0022s27.4
  • Hypothalamic networks and energy homeostasis
  • • PYY and the regulation of appetite control

      ea0022s28.1
    • Brain lipogenesis and the control of food intake: the lipostatic hypothesis revisited

      ea0022s28.2
    • Hypothalamic plasticity and the central control of energy balance

      ea0022s28.3
• Highlights
• • Oral Communications Highlights 1
  • • PEX11[beta] deficiency impaired ossification by indirectly activating PPAR[gamma] expression and diminishing Runx2 activity

      ea0022h1.1
    • Novel pathogenetic pathways of adrenocortical tumors revealed by meta-analysis of genomics data

      ea0022h1.2
    • Frequent phosphodiesterase 11a (pde11a4) gene mutations in patients with carney complex (cnc) due to prkar1a mutations and adrenal (ppnad) and Sertoli cell tumors (lccsct): a digenic disorder?

      ea0022h1.3
    • Physiological rescue by functional complementation of mutated LH receptors in transgenic mice

      ea0022h1.4
    • Different genes are involved in Pendred's syndrome and in enlarged vestibular aqueduct syndrome

      ea0022h1.5
  • Oral Communications Highlights 2
  • • The endocannabinoid action in the regulation of energy balance is mainly due to the CB1 receptor in the forebrain neurons

      ea0022h2.1
    • Human recombinant GH replacement therapy in children with pseudohypoparathyroidism type Ia and GH deficiency: first study on the effect on growth

      ea0022h2.2
    • Subtle cognitive impairments in patients with long-term cure of Cushing's disease

      ea0022h2.3
    • TAC3 and TACR3 'Knockouts' cause hypothalamic congenital hypogonadotropic hypogonadism in humans

      ea0022h2.4
    • Effects of leptin administration on starvation-induced alterations in hepatic thyroid hormone metabolism in mice

      ea0022h2.5
• Oral Communications
• • Diabetes and obesity
  • • Role of newly identified immunosuppressive NK cells in autoimmunity

      ea0022oc1.1
    • Glucose insulinotropic peptide (GIP) secretion in type 2 diabetic and obese non-diabetic persons examined by meal test

      ea0022oc1.2
    • NME7: a new candidate gene for T2DM

      ea0022oc1.3
    • The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction

      ea0022oc1.4
    • Role of PKA regulatory subunit R2B in murine and human adipocyte differentiation

      ea0022oc1.5
    • Variation in response to exercise in type 2 diabetes associated to VEGFA and PGC1-[alpha] expression

      ea0022oc1.6
  • Thyroid
  • • Calcitonin screening and pentagastrin testing: predictive value for diagnosis medullary carcinoma in nodular thyroid disease

      ea0022oc2.1
    • Systemic sodium iodide symporter (NIS) gene transfer in hepatocellular carcinoma using EGF-receptor targeted non-viral gene delivery vectors

      ea0022oc2.2
    • Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies

      ea0022oc2.3
    • Polyglandular autoimmunity in autoimmune thyroid disease behaves differently from polyglandular autoimmunity in type 1 diabetes

      ea0022oc2.4
    • Thyroid dysfunction related abnormalities in adiponectin and glucose metabolism before and after treatment

      ea0022oc2.5
    • Percutaneous laser ablation (PLA) in non-functioning benign thyroid nodules: a 3-year follow-up study

      ea0022oc2.6
  • Pituitary
  • • Sgk1 effects on POMC transcription and ACTH release are opposite to those of glucocorticoids

      ea0022oc3.1
    • Copeptin, an arginine vasopressin (AVP) marker, as a diagnostic aid in SIADH of cancer

      ea0022oc3.2
    • Trauma severity, but not hypopituitarism, affects cognitive function after traumatic brain injury: a multi-center study in The Netherlands

      ea0022oc3.3
    • Influence of the d3-GH receptor polymorphism on the metabolic and biochemical phenotype of GH deficient adults at baseline and during short- and long-term rhGH replacement therapy

      ea0022oc3.4
    • Cortisol, but not ACTH/CRH, increases circulating ghrelin in man

      ea0022oc3.5
    • Young patients with sporadic macroadenomas as target population for AIP mutations screening

      ea0022oc3.6
  • Adrenals
  • • Subtype differentiation in primary hyperaldosteronism: evaluation of alternative algorithms avoiding a controversial gold standard

      ea0022oc4.1
    • A mouse model with hyperaldosteronism carrying an ENU induced mutation on chromosome 9

      ea0022oc4.2
    • Novel mutations in the glucocorticoid receptor gene: from familial bilateral adrenal hyperplasia to glucocorticoid receptor haploinsufficiency

      ea0022oc4.3
    • Combined anticortisolic therapy by metyrapone, ketoconazole and mitotane: an alternative to adrenalectomy in severe Cushing's syndrome

      ea0022oc4.4
    • Effects of mitotane on testicular adrenal rest tumors size, sperm count and adrenal steroidogenesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0022oc4.5
    • Serum cortisol predicts increased cardiovascular mortality in patients with acute coronary syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

      ea0022oc4.6
  • Reproduction & Thyroid
  • • Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model

      ea0022oc5.1
    • The influence of cure of subclinical hyperthyroidism on diastolic diameters of heart chambers and cardiac index

      ea0022oc5.2
    • Socio-economic factors and mortality in Turner syndrome: a registry study

      ea0022oc5.3
    • One hormone, two functions: the chorionic gonadotropin in New World Monkeys

      ea0022oc5.4
    • Predictive factors of intermittent ovarian function in patients with premature ovarian failure

      ea0022oc5.5
    • Universal screening detects twice more thyroid disorders in early pregnancy than targeted high-risk case finding

      ea0022oc5.6
  • Bone
  • • A proteomic approch to study parathyroid glands

      ea0022oc6.1
    • Association between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism

      ea0022oc6.2
    • Six novel mutations in 25-hydroxyvitamin D3 1[alpha] hydroxylase gene in patients with pseudovitamin D deficiency rickets

      ea0022oc6.3
    • Age-dependent features of bone mineral density changes in male rats with hyperthyroidism

      ea0022oc6.4
    • The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma

      ea0022oc6.5
    • Suppression of circulating fibroblast growth factor-23 by cinacalcet in patients with primary hyperparathyroidism

      ea0022oc6.6
• Poster Presentations
• • Adrenal
  • • Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound

      ea0022p1
    • Alterations in lipid and carbohydrate metabolism in patients with classic CAH due to 21-hydroxylase deficiency

      ea0022p2
    • Glucocorticoid receptor polymorphisms and metabolic-cardiovascular impairment in adult patients with Addison's disease under glucocorticoid replacement therapy

      ea0022p3
    • Clinically silent adrenal incidentalomas: their relation to metabolic syndrome and to GNB3 C825T gene polymorphism

      ea0022p4
    • Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome: a longitudinal study

      ea0022p5
    • Supine and upright plasma renin (PR) and aldosterone (ALD) in patients with adrenal incidentaloma (AI)

      ea0022p6
    • Beneficial metabolic effects of surgical treatment in patients with an adrenal incidentaloma causing subclinical hypercortisolism

      ea0022p7
    • The consideration of external steroid therapy history and skin bruising sign with morning serum cortisol measurement predicts better results of rapid ACTH stimulation test than morning serum cortisol only

      ea0022p8
    • A high prevalence of primary hyperaldosteronism in hypertensive patients

      ea0022p9
    • Cushing's syndrome: screening and diagnosis aspects

      ea0022p10
    • Effects of atenolol add-on treatment on plasma renin activity (PRA) and aldosterone escape in hypertensive patients with diabetes receiving valsartan

      ea0022p11
    • Autoimmune disorders in Addison's disease and in isolated secondary adrenal insufficiency

      ea0022p12
    • Pharmacokinetic evidence for hydrococortisone under and over replacement in adrenal insufficiency

      ea0022p13
    • Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate as markers of disease severity in community-acquired pneumonia

      ea0022p14
    • Pheochromocytoma in an incidentally discovered cystic adrenal mass: a case report

      ea0022p15
    • Secondary adrenal failure due to sepsis

      ea0022p16
    • Salivary cortisol in the diagnosis of Cushing's syndrome: clinical experience with liquid chromatography/tandem mass spectrometry on outpatient basis

      ea0022p17
    • The aldosterone renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma

      ea0022p18
    • Adrenal incidentalomas accompanying malignant tumours: clinical study of 1888 patients

      ea0022p19
    • Comparison between ultrasonography versus other standard imaging procedure in diagnostics of pathological changes of adrenal glands

      ea0022p20
    • Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects

      ea0022p21
    • Comparison of the in vitro effects of ketoconazole and fluconazole on human primary adrenocortical cultures and on the adrenocortical carcinoma cell line HAC15

      ea0022p22
    • Sunitinib decreases adrenocortical cancer cell proliferation and specifically inhibits adrenal steroidogenesis

      ea0022p23
    • Two cousins with 17-[alpha] hydroxylase enzyme deficiency

      ea0022p24
    • Morphological, functional and metabolic features in a series of 63 patients with adrenal incidentalomas

      ea0022p25
    • Confirmation of vitamin D receptor polymorphism TaqI and detection of a new single nucleotide polymorphism (SNP) in the CTLA4-region (CTLA4-CT60) as susceptibility markers for Addison's disease

      ea0022p26
    • Spontaneous recovery of bone mass after cure of endogenous hypercortisolism

      ea0022p27
    • Predictors for cure and normotension after adrenalectomy for primary aldosteronism

      ea0022p28
    • Benefit to risk ratio of mitotane high starting dose strategy in 22 patients with adrenocortical carcinoma (ACC): a prospective evaluation

      ea0022p29
    • Primary adrenocortical sarcomatous carcinoma: case report

      ea0022p30
    • Adrenocortical cancer: any hope? case reports

      ea0022p31
    • Utility of midnight salivary cortisol measurement in the diagnosis of overt and subclinical Cushing's syndrome

      ea0022p32
    • Adrenal incidentalomas and low grade hormonal activity

      ea0022p33
    • Aberrant adrenal LH receptors leading to subclinical Cushing's syndrome: long-term effect of medical treatment with leuprolide acetate

      ea0022p34
    • Conservation and divergence in transcriptional regulation of human CYP11B1 and CYP11B2 genes

      ea0022p35
    • Free cortisol in plasma and saliva samples after synacthen testing in a routine exploration of patients in endocrinology

      ea0022p36
    • Inactivation of PRKARIA or PRKAR2B increases cell proliferation and decreases apoptosis, delineating distinct molecular mechanisms in adrenocortical human H295R cell line

      ea0022p37
    • Cortisol resistance in a HIV infected patient

      ea0022p38
    • The measurement of epicardial fat thickness is an index of cardiometabolic risk in patients with adrenal incidentaloma

      ea0022p39
    • Higher cortisol response to glucose load in patient with adrenal adenomas and subclinical Cushing (SC)

      ea0022p40
    • Response of human adrenocortical carcinoma to mitotane treatment in vitro

      ea0022p41
    • Increased prevalence of metabolic syndrome in patients with subclinical autonomous cortisol hypersecretion by adrenal incidentalomas

      ea0022p42
    • Comparison of physiological and endocrine responses of rainbow trout (Oncorhynchus mykiss) after electroanesthesia and anesthesia with MS222 and clove oil

      ea0022p43
    • Pheochromocytoma of the adrenal gland scaled score (PASS) as a predictor of aggressive biologic behaviour

      ea0022p44
    • High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: implications to management

      ea0022p45
    • Profile of cortisol changes during early stages of development in rainbow trout

      ea0022p46
    • Genomic DNA alterations in adrenocortical tumors (ACTs): diagnostic and prognostic value

      ea0022p47
    • Combined primary aldosteronism and preclinical Cushing's syndrome due to a large adrenocortical adenoma

      ea0022p48
    • In vitro effect of dopastatins on hormone secretion in adrenal tumors

      ea0022p49
    • Under-expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone producing adenoma causing human primary aldosteronism

      ea0022p50
    • In vitro effect of serotonin (5-HT) on cortisol secretion in primary pigmented nodular adrenal disease

      ea0022p51
    • Expression of mTOR and IGF2 and in vitro effects of mTOR inhibitor drugs on cell proliferation and cortisol production in human adrenocortical cancer cells

      ea0022p52
    • Primary bilateral adrenal lymphoma without adrenal insufficiency: a case report

      ea0022p53
    • Cushing's syndrome in children: new faces of the old one

      ea0022p54
    • Influence of various clinical variables and storage conditions on urinary cortisol levels: gas chromatography-mass spectrometry (GC-MS) versus immunoassay

      ea0022p55
    • Arterial and venous thrombotic events in Cushing's syndrome

      ea0022p56
    • Influence of short-term glucocorticoid therapy on regulatory T cells

      ea0022p57
    • Long-term follow-up of patients with adrenal incidentalomas: a single center experience

      ea0022p58
    • QTc and P wave dispersion in patients with Cushing's syndrome

      ea0022p59
    • Laparoscopic adrenalectomy: 12-year experience in a single institution

      ea0022p60
    • Comparison of plasma aldosterone/signal activity and aldosterone/active signal ratios in different clinical conditions

      ea0022p61
    • Adrenal incidentaloma; a case report

      ea0022p62
    • Adrenal non-producing adenomas show indirect signs of glucocorticoid excess and hypercortisolism correlates with differential blood counts

      ea0022p63
    • Endothelial cell-derived products regulate [beta]-catenin-dependent transcription in human adrenocortical cells

      ea0022p64
    • Sporadic solitary aldosterone- and cortisol-cosecreting adenomas: a subtype of primary aldosteronism

      ea0022p65
    • The HLA-DRB1 shared epitope and trans-encoded HLA-DQ-heterodimers hypothesis in autoimmune Addison disease

      ea0022p66
  • Bone/Calcium
  • • Estimation of ionized calcium levels after thyroidectomy at King Abdul Aziz University Hospital (Jeddah)

      ea0022p67
    • Imatinib mesylate disturbs bone growth and remodellation in postnatal rats

      ea0022p68
    • Parathyroid hormone levels in hemodialysis patients

      ea0022p69
    • Bone mineral density in Ukrainian women of different age with thyrotoxicosis

      ea0022p70
    • Relationship of serum leptin and bone mineral density in patients with type 2 diabetes mellitus

      ea0022p71
    • Study implications osteoporosis in gonadal disgenesias

      ea0022p72
    • Bone mineral density study and biochemical markers of bone turnover in premature ovarian failure

      ea0022p73
    • Delayed puberty and bone turnover biochemical markers

      ea0022p74
    • Structural heart disease in osteogenesis imperfecta: a case-control study

      ea0022p75
    • Osteomalacia: important cause of bone loss in a patient with inflamatory bowl disease: case report

      ea0022p76
    • The effect of zoledronic acid on serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone

      ea0022p77
    • Angiotensin converting enzyme I/D and M235T angiotensinogen gene polymorphism in patients with acromegaly

      ea0022p78
    • Cutoff point, upper and lower QUS parameters values in diagnosing demineralisation in cases with ESRD

      ea0022p79
    • Secondary hypoparathyroidism in thalassaemia and sickle cell anaemia

      ea0022p80
    • Abnormalities in calcium, phosphorus and parathyroid hormone in patients with end stage chronic kidney disease on hemodialysis

      ea0022p81
    • An unusual cause of life-threatening hypercalcaemia treated with haemodialysis

      ea0022p82
    • The markers of bone remodelling in postmenopausal osteoporosis

      ea0022p83
    • Effect of strontium ranelate on vertebral pain syndrome in postmenopausal women with systemic osteoporosis treatment

      ea0022p84
    • Giant mediastinal parathyroid adenoma, a rare cause of severe acute hyperparathyroidism

      ea0022p85
    • Mandibular radiomorphometric indices as predictors of osteopenia and osteoporosis in postmenopausal women

      ea0022p86
    • Asymptomatic primary hyperparathyroidism: current indications for final solution

      ea0022p87
    • Vitamin D and calcium status in women with postmenopausal osteoporosis

      ea0022p88
    • Comparison of alendronate and raloxifene as a medical treatment option in patients with primary hyperparathyroidism

      ea0022p89
    • Primary hyperparathyroidism: retrospective evaluation

      ea0022p90
    • Long-term follow-up of the changes in serum 25-hydroxivitamin D to oral treatment with vitamin D3 in patients with postmenopausal osteoporosis

      ea0022p91
    • Management of primary hyperparathyroidism in Spain: a national survey

      ea0022p92
    • Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency

      ea0022p93
    • Dissimilar PTH, gastrin, and ionized calcium response to oral peptones in normocalcemic primary hyperparathyroidism, hypercalcemic primary hyperparathyroidism and normal subjects

      ea0022p94
    • Cross-validated calculation procedure to assess the cholecalciferol loading dose for rapid correction of vitamin D deficiency

      ea0022p95
    • Hypoparathyroidism mimicking ankylosing spondylitis

      ea0022p96
    • Multiple osteoporotic fractures in myasthenia gravis patient receiving short-term prednisolone therapy

      ea0022p97
    • Teriparatide in the treatment of severe osteoporosis: results of a multicenter prospective study

      ea0022p98
    • Vitamin D deficiency and comorbidity

      ea0022p99
    • Vitamin D status among adults in the Aegean region of Turkey

      ea0022p100
    • Fine needle aspiration of parathyroid gland with PTH analysis in washouts: is it worthy?

      ea0022p101
    • Positive effect of human adipocyte-secreted factors on human osteoblast proliferation and the OPG/RANKL ratio in vitro

      ea0022p102
    • Tumoral calcinosis likely due to end-organ resistance to FGF23

      ea0022p103
    • Wermer syndrome revealed by primary hyperparathyroidism: a case report

      ea0022p104
    • Severe primary hyperparathyroidism related multiple clear cell adenome

      ea0022p105
    • Osteocalcin, OPG and RANKL circulating levels in adolescent idiopathic scoliosis

      ea0022p106
    • Parathyroid FNA with PTH determination as a tool in primary hyperparathyroidism diagnosis - case report

      ea0022p107
    • Bone turnover, serum osteoprotegerin and soluble receptor activator of nuclear factor-K ligand levels in patients with hyperthyroidism

      ea0022p108
    • Primary hyperparathyroidism at pregnancy

      ea0022p109
    • Comparative evaluation of bone density measurement with DXA or quantitative ultrasound of bone in the diagnosis and treatment monitoring of osteoporosis - a field study

      ea0022p110
    • Osteoporosis and osteopenia in patients after the organ transplantation

      ea0022p111
    • Risk of vertebral fractures in osteoporotic women: definition of a clinically relevant scale of risk

      ea0022p112
    • Diagnostic challenge in child's bone cystic lesions

      ea0022p113
    • Male osteoporosis of multiple drug aetiology

      ea0022p114
    • Extraosseous effects of raloxifene in osteoporotic postmenopausal women

      ea0022p115
    • Polyunsaturated fatty acids omega-3, but not the omega-6, stimulates the differentiation to osteoblasts of mesenchymal stem cell

      ea0022p116
    • Evaluation of age and sex influence on the morphometric parameters of vertebrae in densitometric morphometry - results of EPOLOS study

      ea0022p117
    • Primary hyperparathyroidism diagnosis - new insights of an old dilemma

      ea0022p118
    • PTH treatment in adult hypophosphatasia: significant increase in S-AP, improvement of pain and fracture healing in two siblings with ALPL gene mutations G339R and E191K

      ea0022p119
    • Estradiol and testosterone levels in diabetic type 2 men with low bone density and osteoporosis

      ea0022p120
    • The circadian rhythm of bone resorption: comparison between patients treated with teriparatide and patients with primary hyperparathyroidism

      ea0022p121
    • Primary hyperparathyroidism: laboratory associations and thyroid pathologies

      ea0022p122
  • Cardiovascular endocrinology and lipid metabolism
  • • Interrelation between bone mineral density and lipid profile in postmenopausal women

      ea0022p123
    • Levels of adiponectin and tumor necrosis factor-alpha in members of families with familial combined hyperlipidemia

      ea0022p124
    • Cardiovascular disease and risk factors in patients with type 2 diabetes in IRAN

      ea0022p125
    • The effect of erythropoietin treatment on insulin resistance and inflammatory markers in patients on maintenance hemodialysis

      ea0022p126
    • Subjects homozygous for the BCL1 polymorphism of glucocorticoid receptor gene may have an increased risk for impaired endothelial function

      ea0022p127
    • Leptin and its associations with complications of acute myocardial infarction in patients with the metabolic syndrome

      ea0022p128
    • Obesity and metabolic syndrome during the menopausal transition of women in Serbia

      ea0022p129
    • The effects of adiponectin gene polymorphisms on the progression of carotid intima-media thickness

      ea0022p130
    • Associations between the metabolic syndrome and bone mineral density in Ukrainian women in postmenopausal period

      ea0022p131
    • Prevalence of metabolic syndrome in a working population of strategic services

      ea0022p132
    • Are the thyroid functions associated with widespread of acute coronary syndromes?

      ea0022p133
    • Effects of cross-sex hormone treatment in young transsexual subjects

      ea0022p134
    • Insulin secretion and HOMA-IR in patients who underwent coronary angiography

      ea0022p135
    • Serum ferritin and risk of the metabolic syndrome in cross-sex hormone-treated transsexuals

      ea0022p136
    • FABP4 inhibitor strongly depresses cardiac function

      ea0022p137
    • Calculation of cardiovascular risk in firefighters

      ea0022p138
    • Echocardiographic epicardial fat thickness in acromegaly patients

      ea0022p139
    • Atrial natriuretic peptide (ANP) attenuates lipid peroxidation in anesthetized atherosclerotic male rabbits by reduction of renin-angotensin-aldosterone system (RAAS) activity

      ea0022p140
    • Serum IGF1 levels correlate to improvement of functional independence after ischemic stroke

      ea0022p141
    • Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial

      ea0022p142
    • Osteopontin, adiponectin and peripherical arterial disease in patients with type 2 diabetes

      ea0022p143
    • Clinical approach to hypertensive patients: matter of trust between doctor and patient

      ea0022p144
    • Ligands of receptor for advanced glycation end-products in stable coronary artery disease: their potential contribution to atherogenesis exceeds beyond diabetes mellitus

      ea0022p145
    • Acromegaly and endothelial dysfunction: is there any relation between?

      ea0022p146
    • Gender variations of serum Paraoxonase-1 activities in healthy young men and women: association with carotid intimae media thickness

      ea0022p147
    • Searching for the metabolic syndrome criteria in young adults with hypogonadism

      ea0022p148
    • Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

      ea0022p149
    • Genetic polymorphisms associated with cardiovascular risk correlate with dyslipidaemia in healthy postmenopausal women

      ea0022p150
    • Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?

      ea0022p151
    • Relationship between serum IL-12 and p40 subunit concentrations and lipid parameters in obese subjects

      ea0022p152
    • Heart rate variability in adults with hypopituitarism and severe growth hormone deficiency

      ea0022p153
    • Increased plasma resistin concentrations are associated with atherogenic small, dense low-density lipoproteins in patients with type-2 diabetes

      ea0022p154
    • Increased plasma viscosity is a predictor of high cardiovascular risk in women with PCOS

      ea0022p155
    • The impact of testosterone replacement therapy on endothelial function in hypogonadal men with type 2 diabetes

      ea0022p156
    • Alterations of plasminogen activator inhibitor-1, myeloperoxidase and matrix metalloproteinase-9 in coronary artery disease patients with type-2 diabetes mellitus

      ea0022p157
    • Osteoprotegerin and angiotensin II in type 2 diabetes

      ea0022p158
    • Changes in serum concentrations and tissue expression of fibroblast growth factor-21 during and after elective major cardiac surgery

      ea0022p159
    • MRI-assessed visceral adipose tissue (VAT) in different lipodystrophic (LD) syndromes

      ea0022p160
    • Possibility for the Metformin administration in post-infarction period in patients with the 2-nd type of DM

      ea0022p161
    • The effect of testesterone replacement therapy on HDL subfraction levels in hypogonadotropic hypogonadism

      ea0022p162
    • Pitfalls in endocrine assessment of systemic hypertension in young people

      ea0022p163
    • Correlation of plasma B-type natriuretic peptide (BNP) levels with electrocardiographic (ECG) signs of right ventricular strain in patients with acute pulmonary embolism

      ea0022p164
    • Male sexuality and cardiovascular risk: a cohort study in patients with erectile dysfunction

      ea0022p165
    • CRH and Urn2 regulate NO bioavailability, ROS levels and antioxidant defence systems in endothelial cells

      ea0022p166
    • Structural and functional carotid wall alterations in controlled versus active acromegaly

      ea0022p167
    • Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme-oxigenase synthase

      ea0022p168
    • Bcl1 polymorphysm of glucocorticoid receptor gene in coronary artery disease

      ea0022p169
    • Formation of neutralizing anti human growth hormone (hGH) antibodies does not explain the lack of IGF1 increase after recombinant hGH treatment in mice

      ea0022p170
  • Clinical case reports and clinical practice
  • • Parathyromatosis coincidentally associated with papillary (Sclerosing) microcarcinoma of the thyroid

      ea0022p171
    • Carcinoid syndrome: case report

      ea0022p172
    • Insulin-induced lipohypertrophy, past, present and future-are we losing the battle?

      ea0022p173
    • 'Sound mind' and lithium-induced hyperparathyroidism

      ea0022p174
    • Fenofibrate-induced rhabdomyolysis and acute renal failure in patient with occult hypothyroidism

      ea0022p175
    • Quality management system of regional and general hospital medical laboratory in relation to ISO 15189:2007, Thailand

      ea0022p176
    • Pursuit endocrinology - perceptions, understanding and reactions of students undertaking internal medicine training regarding endocrinology

      ea0022p177
    • Glass fiber containing materials - a rare cause of granulomatous mastitis

      ea0022p178
    • Screening for nutritional status in the elderly

      ea0022p179
    • Papillary thyroid carcinoma in a patient with intestinal ganglioneuromatosis

      ea0022p180
    • Syndrome of inappropiate antidiuresis hormone associated with multiple sclerosis

      ea0022p181
    • Occult ACTH-secreting pheochromocytoma

      ea0022p182
    • Metastasis to the thyroid gland with thrombo embolic jugular involvement as initial presentation of renal carcinoma: a Case Report

      ea0022p183
    • Emergency use of etomidate in acute steroid psychosis for an adrenal cancer causing Cushing's syndrome

      ea0022p184
    • Primary biliary cirrhosis and Graves' disease - combination rarely found

      ea0022p185
    • Pseudophaeochromocytoma: case series of a common cause

      ea0022p186
    • An uncommon case of Carney's triad

      ea0022p187
    • Case report of Borrelia burgdorferi infection as a possible trigger of Riedel's thyroiditis

      ea0022p188
    • Liver toxicity after methylprednisolone treatment of Graves orbitopathy

      ea0022p189
    • Cryopreserved organ culture of endocrine glands for hormonal insufficiency treatment

      ea0022p190
    • Nonclassic 11-hydroxylase deficiency with hypofunctional polymorphisms on both haplotype

      ea0022p191
    • Approaches to the diagnosis and management of primary hyperparathyroidism in Europe results from a European Survey in five countries

      ea0022p192
    • An unusual case of acromegaly

      ea0022p193
    • Thyroid storm accompanied by H1N1 influenza infection

      ea0022p194
    • A rare cutaneous manifestation in Cushing's syndrome: generalized pustular psoriasis

      ea0022p195
    • A rare cause of elevated liver enzymes: Addison's disease

      ea0022p196
    • Genetic pattern of sex development disorders: cases report

      ea0022p197
    • Administration of testosterone to elderly hypogonadal men with Crohn's disease improves their Crohn's disease activity index: a pilot study

      ea0022p198
    • Papillary thyroid carcinoma metastasis to the parapharyngeal space

      ea0022p199
    • Evolution of thyroid angiosarcoma under complex therapy: a case report

      ea0022p200
    • A successfull case of pregnancy in a woman with ACTH-independent Cushing's syndrome

      ea0022p201
    • Oral bisphosphonates - therapeutical results after two years treatment in osteogenesis imperfrecta type Ia

      ea0022p202
    • Long-standing testicular adrenal rest tissues in a patient with congenital adrenal hyperplasia due to 11-beta hydroxylase deficiency with homozygous mutation l299p in the Cyp11b1 gene

      ea0022p203
    • Ganglioneuroblastoma: a rare cause of adrenal mass in adults

      ea0022p204
    • Amiodarone induced thyreopaties

      ea0022p205
    • The role of salivary [alpha]-amylase in prediction of failure of smoking cessation

      ea0022p206
    • Childhood nephrogenic diabetes insipidus revealed by urinary megabladder in two adult male brothers

      ea0022p207
    • A family with Von Hippel - Lindau disease (VHL)

      ea0022p208
    • The use of an algorithm to aid diagnosis and treatment of patients with hyponatraemia secondary to SIADH

      ea0022p209
    • Two rare genetic causes of aberrant growth: Robinow syndrome with partial GH deficiency and dwarfism and Simpson-Golabi-Behmel syndrome with gigantism

      ea0022p210
    • Unilateral Graves' orbitopathy and autoimmune atrophic thyroiditis: case report

      ea0022p211
    • The difficulties of Cushing' s disease - case report

      ea0022p212
    • The role of octreotide in the management of young patients with acromegaly

      ea0022p213
    • Thyroid antibodies and renal function

      ea0022p214
    • The etiologic profile of short stature in the south west of Romania between 2004-2009

      ea0022p215
    • 10 years experience with somatostatin analogue (SSA) treatment in multiple endocrin neoplasia type 1 (a case report)

      ea0022p216
    • Malignant corticotrophinoma - a clinical report

      ea0022p217
    • Differences in TSH lowering effect of metformin in hypothyroid and euthyroid type 2 diabetic patients

      ea0022p218
    • Secondary osteoporosis and secondary hyperparathyroidism in patient with Hashimoto thyroiditis and coeliac disease (case report)

      ea0022p219
    • Primary ovarian carcinoid presenting as right heart failure - case report

      ea0022p220
    • Two therapeutic approaches for thyrotropin-secreting pituitary adenomas

      ea0022p221
    • A retroperitoneal neuroendocrine tumour pre-diagnosed as an adrenal incidentaloma - a case report

      ea0022p222
    • Hypoparathyroidism related epilepsy

      ea0022p223
    • Graves' disease, systemic lupus erythematosus, hypoparathyroidism: autoimmune polyglandular syndrome or coincidence?

      ea0022p224
    • Necrotizing fasciitis as a complication of subcutaneous injection of insulin in a diabetic patient: a case report

      ea0022p225
    • Pancreatic graft arterial thrombosis after coronary artery catheterization - an unusual case of pancreas allograft rejection

      ea0022p226
    • Hypogonadotropic hypogonadism in POEMS syndrome - case report

      ea0022p227
    • Cushing's syndrome as presentation of an ACTH-producing pulmonary tumour

      ea0022p228
    • Dose of growth hormone (GH) and not IGFI level at treatment start influences treatment outcome in GH deficient adults (GHDA): Data from the NordiNet International Outcome Study (IOS)

      ea0022p229
    • Fluctuating bilateral abducent palsy leading to the diagnosis of pituitary mass without cavernous sinus involvement. How does this match?

      ea0022p230
    • Isolated parietal-skull metastasis from a thyroid papillary carcinoma

      ea0022p231
    • Benign symmetric lipomatosis (Madelung's disease): a case report

      ea0022p232
    • Pheochromocytoma associated with thyroid papillary carcinoma: a report of an unusual case

      ea0022p233
    • Primary adrenal failure of tuberculous aetiology and vitamin D deficiency

      ea0022p234
    • Carbimazole induced neutropenia: are we too cautious?

      ea0022p235
    • Carbimazole pseudo-resistance: two case reports

      ea0022p236
    • Estimation of parathyroid hormone level in patients with primary hyperparathyroidism (PHPT) and negative SPECT scans in the material obtained during fine needle aspiration biopsy (FNAB) of the focal neck lesions

      ea0022p237
    • A case of severe hypocalcaemia post liver transplantation

      ea0022p238
    • Causes and patterns of death in an endocrinology clinic: data of six years

      ea0022p239
    • Synergic effect of Cabergoline in acromegaly treated with somatostatin analogues. Report of two cases

      ea0022p240
    • Macroprolactinoma after chronic buserelin treatment in patient with prostate cancer

      ea0022p241
    • Diagnostic performance evaluation of marking the concentration levels of procalcitonin and ProGRP in monitoring disease cases of patients with medullary thyroid carcinoma (MTC)

      ea0022p242
    • Nesidioblastosis in adult patient with neurofibromatosis type1 and synchronous multicentric duodenal somatostatinomas - case report

      ea0022p243
    • Polyuric-polydipsic syndrome after cranioencephalic traumatism in a patient with multiple sclerosis

      ea0022p244
    • The course of disease and treatment of patient with MEN2A syndrome diagnosed in 9-th week of pregnancy

      ea0022p245
    • Serum prolactin levels in rheumatoid arthritis and other autoimmune diseases

      ea0022p246
    • A tale to tell: how lupus led to Graves' disease

      ea0022p247
    • Tertiary hypercorticotropinism and Cushing's disease secondary to impaired 21-hydroxylation

      ea0022p248
    • Cushing syndrome in patient with thyroid orbitopathy (case report)

      ea0022p249
    • Different manifestations of polyglandular autoimmune syndrome in HLA-identical monozygous twins

      ea0022p250
  • Comparative endocrinology
  • • Relationship between essential amino acids and muscle mass, independent of habitual diets, in pre- and post-menopausal women

      ea0022p251
    • Comparison of delayed puberty in girls and boys- Bosnian aspect

      ea0022p252
    • Osmoregulatory related alterations in plasma levels of triiodothyronine and cortisol in a marine euryhaline teleost

      ea0022p253
    • Growth hormone releasing hormone (GHRH)-like peptide (LP)-2 is a growth hormone (GH) releasing factor in chickens

      ea0022p254
    • Pituitary adenylate cyclase-activating polypeptide related peptide (PRP) in an Anabantidae fish: its mRNA expression in the brain during gonadal development and sexual behavior and its hypophysiotropic effect on pituitary hormonal gene expression

      ea0022p255
  • Developmental endocrinology
  • • Similar developmental patterns of ghrelin and glucagon immunoreactivity in the human pancreas

      ea0022p256
    • Mineralocorticoid pathway in newborns: evidence for a physiological renal aldosterone unresponsiveness

      ea0022p257
    • De novo cholesterol synthesis in developing mouse embryo is required for embryonic survival

      ea0022p258
    • Partial loss of pancreas endocrine and exocrine cells of human ARX-null mutation: consideration of pancreas differentiation

      ea0022p259
    • Quality of life and emotional state of adult patients with adult-onset, childhood-onset growth hormone deficiency and Turner syndrome

      ea0022p260
    • An inadequate maternal dietary protein level during pregnancy in pigs alters the expression of corticosteroid receptors and 11[beta]-hydroxysteroid dehydrogenase isoforms in the placenta and fetal brain

      ea0022p261
    • Lipid profile in type 2 diabetic patients in Kragujevac

      ea0022p262
    • Gonadal structures in a fetus with complete androgen insensitivity syndrome and persistent Mullerian derivatives: comparison with the normal fetal development

      ea0022p263
    • Baseline characteristics and serum IGF1 levels in GH deficient (GHD) patients treated in the transition phase from adolescence into adulthood: data from the NordiNet International Outcome Study (IOS)

      ea0022p264
    • Maternal stress in early pregnancy: the reason of endocrine and behaviour disorders in female offspring

      ea0022p265
    • Familial hypercalciuric hypercalcemia and severe neonatal hyperparathyroidism: a clinico-biochemical and molecular characterization in a Tunisian family

      ea0022p266
  • Diabetes
  • • Have the glitazones anything to do with fractures?

      ea0022p267
    • Insulin-induced lipohypertrophy, past, present and future: are we losing the battle?

      ea0022p268
    • Body mass index, disease duration and rheumatologic presentations in diabetes mellitus, Gorgan (North part of Iran)

      ea0022p269
    • A case of diabetic ketoacidosis with ECG abnormalities mimicking acute coronary syndrome

      ea0022p270
    • The role of ATP-sensitive potassium (KATP) channel in skeletal muscle insulin resistance: possible correlation with GLUT4 gene

      ea0022p271
    • Depression, anxiety, quality of life and sleep in patients with type 1 diabetes mellitus

      ea0022p272
    • The effect of diabetes treatment on non alcoholic fatty liver disorder

      ea0022p273
    • Insulin resistance in smokers and non-smokers in young healthy population

      ea0022p274
    • Benefit of switching from rosiglitazone to pioglitazone on cardiovascular markers in routine clinical practice

      ea0022p275
    • Advanced glycation end products (AGEs) and high glucose in endothelial cells: gene expression analysis

      ea0022p276
    • Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients

      ea0022p277
    • Assessment of the therapeutic effectiveness of gliclazide MR after short-term application

      ea0022p278
    • Effectiveness of patterns of intensification of premixed insulin analogue therapy

      ea0022p279
    • Knowledge, attitudes and practices of type 1 diabetes patients regarding complementary and alternative medicine (CAM)

      ea0022p280
    • The frequency of depression estimation among patients with diabetes mellitus

      ea0022p281
    • The Gly972Arg polymorphism in the insulin receptor substrate-1 gene (IRS1) and the impact on type 2 diabetes mellitus

      ea0022p282
    • Impact of the SUR1 16-3 C/T and INSR His 1085 C/T genetic variability on type 2 diabetes mellitus development

      ea0022p283
    • Left ventricular hypertrophy and its relation with inflammation in type 2 diabetic patients

      ea0022p284
    • Abstract unavailable

      ea0022p285
    • It's time to put the 'age' and the 'face' on HbA1c in elderly patients with diabetes mellitus

      ea0022p286
    • Depression, anxiety, quality of life and sleepiness in family members of type 2 diabetic patients

      ea0022p287
    • Comparative and metabolic study of glycosylated hemoglobin, magnesium, nitrogenous metabolites, and lipid profile in diabetics and non-diabetics patients

      ea0022p288
    • Association of diabetes mellitus with thalassaemia and sickle cell disease

      ea0022p289
    • Response of interleukin-6 during euglycaemic and hyperglycaemic exercise in patients with type 1 diabetes mellitus

      ea0022p290
    • Coagulation inhibitors in type 2 diabetes mellitus

      ea0022p291
    • Linagliptin, a potent and selective DPP-4 inhibitor, does not prolong the QT interval when given in therapeutic and 20-fold supratherapeutic doses

      ea0022p292
    • Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation

      ea0022p293
    • In-patients insulin therapy protocol: establishment and valuation

      ea0022p294
    • Insulin treatment intensification to basal-bolus in diabetic patients

      ea0022p295
    • Prevalence of cardiovascular risk factors at the time of diagnosing type 2 diabetes mellitus: follow up in the endocrinologist's consultation

      ea0022p296
    • Evaluation of effect of dose and duration of treatment with metformin on serum vitamin B12 levels in type 2 diabetic patients

      ea0022p297
    • The IMPERIAL study: physicians' perceptions regarding intensification of insulin therapy

      ea0022p298
    • A case of spontaneous pneumomediastinum and diabetic ketoacidosis in patient with diabetes mellitus which was undiagnosed before

      ea0022p299
    • Inpatient hypoglycaemia: the continuing problem and need for a proactive management protocol

      ea0022p300
    • Hypovitaminosis D and microvascular complications in diabetic patients

      ea0022p301
    • Effects of interleukin-4 on energy metabolism

      ea0022p302
    • Metabolic control in patients with type 1 diabetes mellitus in Belarus

      ea0022p303
    • Psychological rehabilitation efficiency in adolescents with type 1 diabetes

      ea0022p304
    • Latent autoimmune diabetes of adults and its clinical, immunological and genetics markers

      ea0022p305
    • Exercise-related levels of acetylcarnitine in skeletal muscle of individuals with type 1 diabetes in Eu- and hyperglycaemia assessed by 1H-MR spectroscopy

      ea0022p306
    • Association between dyslipidaemia and micro and macrovascular complications in type 2 diabetic patients

      ea0022p307
    • Pattern of type 2 diabetes mellitus in Surabaya, Indonesia

      ea0022p308
    • Metabolic syndrome in patients with type 2 diabetes mellitus in Surabaya, Indonesia

      ea0022p309
    • Profile of patients with type 2 diabetes mellitus in Surabaya, Indonesia

      ea0022p310
    • Risk estimation of hypoglycemic episodes among patients with type 1 diabetes mellitus

      ea0022p311
    • The effects of short-term fasting on insulin sensitivity and inflammation in healthy subjects

      ea0022p312
    • Fifty-two-week treatment with diet and exercise plus transdermal testosterone improves biomarkers of non-alcoholic fatty liver disease and cardiovascular risk in hypogonadal men with the metabolic syndrome

      ea0022p313
    • Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes

      ea0022p314
    • Vitamin D deficiency and isolated fasting hyperglycemia in pregnancy

      ea0022p315
    • Postpartum evaluation of patients with gestational diabetes and newborns characteristics: differences between two periods

      ea0022p316
    • Thyroid diseases in patients with type 1 diabetes mellitus

      ea0022p317
    • Proinflammatory cytokines and serum lipids in patients with diabetes mellitus 2

      ea0022p318
    • Non-invasive cytological method of diagnostics and monitoring of type 2 diabetes mellitus development

      ea0022p319
    • Calcaneal spur incidence is increased in patients with type 2 diabetes mellitus

      ea0022p320
    • Analysis of the clinical course of patients with type 2 diabetes mellitus from onset of insulin treatment (EDIN study): baseline characteristics of patients

      ea0022p321
    • Badly controlled hyperglycaemia provokes arrhythmia and may increase cardiovascular risk in diabetic patients

      ea0022p322
    • Etiologies of patients admitted to emergency department with hypoglycemia

      ea0022p323
    • Dose--response characteristics for effects of insulin in patients with type 2 diabetes and severe insulin resistance: evidence for the utility of high doses of insulin

      ea0022p324
    • Interrelation of changes of interval QT and indexes of metabolic control in children with diabetes mellitus type 1

      ea0022p325
    • Pancreatic insulin secretion in women with polycystic ovary syndrome

      ea0022p326
    • Chitotriosidase activity predicts endothelial dysfunction in type 2 diabetes mellitus

      ea0022p327
    • Follow up of type 1 diabetic patients treated with insulin continuous s.c. infusion

      ea0022p328
    • Effects of ghrelin treatment to promote proliferation of pancreatic islet in BB rats

      ea0022p329
    • Lipid profile in patients with ST-segment elevation myocardial infarction with or without diabetes

      ea0022p330
    • Transient insulin resistance during the laparoscopic versus open cholecystectomy

      ea0022p331
    • The mean HbA1c values in T2DM according a therapy regiments

      ea0022p332
    • Therapy with exenatide: our experience

      ea0022p333
    • Prevalence of metabolic syndrome and diabetes mellitus type 2 under the conditions of the primary component of public health

      ea0022p334
    • Adiponectin time dependence secretion under [beta]3 agonist, PPAR agonist treatments

      ea0022p335
    • Therapeutic objectives in the care of patients with diabetes mellitus type 2 in clinical practice at an endocrine department

      ea0022p336
    • The effect of short-term metformin therapy on C-reactive protein and insulin sensitivity in newly diagnosed patients with type 2 diabetes mellitus

      ea0022p337
    • Vitamin D and glycaemic control

      ea0022p338
    • Maternal obesity and gestational diabetes mellitus

      ea0022p339
    • Performances of the fully automated Liaison[reg] system for determination of insulin and C-peptide concentrations

      ea0022p340
    • Role of regulatory T-cells in the development of the partial remission period in patients with type 1 diabetes

      ea0022p341
    • Lipid profile in women with gestational diabetes mellitus

      ea0022p342
    • Increased insulin resistance is associated with increased urinary excretion of chromium in non-diabetic, normotensive Saudi adults

      ea0022p343
    • Systemic effect of insulin on local cytokine concentrations in adipose tissue and muscle in healthy humans

      ea0022p344
    • Decreased serum brain-derived neurotrophic factor concentration in young nonobese subjects with low insulin sensitivity

      ea0022p345
    • Microvascular reactivity and oxidative stress after standard breakfast in patients with recently diagnosed type 2 diabetes

      ea0022p346
    • Quantitative and qualitative changes in T regulatory lymphocytes (Tregs) in newly-diagnosed patients with type 1 diabetes

      ea0022p347
    • Vanishing testes syndrome associated with diabetes mellitus

      ea0022p348
    • The high prevalence of abnormal cardiac function in diabetic patients of a developing community

      ea0022p349
    • The GG genotype of the G-11391A ADIPOQ polymorphism might be a risk factor for development of type 2 diabetes mellitus in women

      ea0022p350
    • Increased serum nesfatin-1 levels in patients with impaired glucose tolerance

      ea0022p351
    • TCF7L2 gene variants and polycystic ovary syndrome

      ea0022p352
    • Insulin sensitivity and acute insulin response in pateints with primary hyperparathyroidism before and after surgical treatment

      ea0022p353
    • Renal complications of aldosteronism and diabetes: role of oxidative stress and protective effects of polyphenol extract

      ea0022p354
    • Prediction of incident diabetes mellitus by baseline insulin-like growth factor 1 levels

      ea0022p355
    • Fasting and postprandial effects of rosiglitazone on low- and high-density lipoproteins size and subclasses in type-2 diabetes

      ea0022p356
    • Levels of adrenomedullin during low dose Synacthen test in diabetics type 1

      ea0022p357
    • Antioxidative effect of green tee and red wine polyphenol extracts on RINm5F cells after oxidative stress induction

      ea0022p358
    • Waiting time for emergency renal replacement therapy in patients with end stage renal failure secondary to diabetes mellitus

      ea0022p359
    • Obestatin and ghrelin inhibit apoptosis of human pancreatic islet endothelial cells in high glucose culture

      ea0022p360
    • Hepatic mitochondrial direct effects of thiazolidinediones: pioglitazone and rosiglitazone

      ea0022p361
    • Glycemic control and treatments in adults with type 1 diabetes mellitus

      ea0022p362
    • Diabetic mastopathy: imaging and management

      ea0022p363
    • Evaluating the effects of vitamin D metabolism on glycemic parameters and atherosclerosis markers in prediabetic patients

      ea0022p364
    • Analysis of incidence and risks factors of gestational diabetes in our area: comparison between two periods

      ea0022p365
    • Disease-modifying drugs in the treatment of intermittent claudication in patients with diabetes mellitus: the pilot study

      ea0022p366
    • Evaluation of HbA1c levels for the detection of prediabetes

      ea0022p367
    • Comparative evaluation of serum concentrations of a novel adipocytokine, fibroblast growth factor-21 in patients with type 2 diabetes and obesity

      ea0022p368
    • The importance of the polymorphism of the AT1-receptor gene in diabetic nephropathy patients

      ea0022p369
  • Endocrine Disruptors
  • • Association between ischemia-modified albumin and oxidative stress markers in patients with metabolic syndrome

      ea0022p370
    • Effects of lambda-cyhalothrin on hematological parameters and testicular functions in male rat

      ea0022p371
    • Evaluation of paraxonase activity, malondialdehyde and thiol levels in patients with hypogonadism before and after treatment

      ea0022p372
    • Micronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegaly

      ea0022p373
    • Paraoxonase is reduced in patients with GH deficiency: a risk factor for atherosclerosis?

      ea0022p374
    • Normal cortisol response to high dose Synacthen and insulin tolerance test in children and adults with Prader--Willi syndrome (PWS)

      ea0022p375
  • Endocrine tumours & neoplasia (Generously supported by Novartis)
  • • Biochemical diagnosis strategy in pheochromocytoma

      ea0022p376
    • Carcinoid syndrome: biochemical diagnosis

      ea0022p377
    • Identification of a novel mutation of MEN1 gene in a patient with persisting primary hyperparathyroidism

      ea0022p378
    • No secreting multiple glucagonoma: one case

      ea0022p379
    • RET codon 618 mutations is the most frequent phenotype in Saudi families with multiple endocrine neoplasia type 2A

      ea0022p380
    • CYP24A1 haplotypes are associated with differentiated thyroid carcinoma

      ea0022p381
    • Surgical treatment of insulinomas: a single-institution experience of 48 patients

      ea0022p382
    • Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience

      ea0022p383
    • Real-time PCR is useful to detect menin gene deletions

      ea0022p384
    • Role of piuitary tumour transforming gene 1 in medullary thyroid carcinoma

      ea0022p385
    • Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability

      ea0022p386
    • GH influences breast cancer chemoresistanec independently of cell cycle perturbations

      ea0022p387
    • Human presentation of MEN X syndrome

      ea0022p388
    • The diagnostic value of PTH concentration in the needle washout after fine-needle biopsy of suspicious cervical foci in patients with hyperparathyroidism

      ea0022p389
    • Sex hormone-binding globulin (SHBG) gene pentanucleotide TAAAA repeat and D327N polymorphism in breast cancer: link to estrogen sensitivity

      ea0022p390
    • Anti-tumor activity of the tumor-vascular-disrupting agent ASA404 (vadimezan) in endocrine tumor models

      ea0022p391
    • Primary hyperparathyroidism and hyperuricaemia and bone turnover

      ea0022p392
    • Bilateral giant myelolipoma of adrenal glands: a case report and review of the literature

      ea0022p393
    • A case of septo-optical dysplasia: are late complications inevitable in spite of early diagnosis and regular follow-up?

      ea0022p394
    • Rare metastases localization in medullary thyroid carcinoma (MTC)

      ea0022p395
    • Outcome of two chemotherapies in the treatment of progressive, undifferentiated neuroendocrine carcinomas: a single-center experience

      ea0022p396
    • Incidence, clinical presentation and outcome of differentiated thyroid cancer in young patients aged 10--24 years living in the French Rhone-Alpes region

      ea0022p397
    • Clinical, hormonal and molecular differences in pituitary ACTH adenomas without (silent corticotroph adenomas) or with Cushing's disease

      ea0022p398
    • Six members of a family with multiple endocrine neoplasia type 2A

      ea0022p399
    • Hepatic transplant and use of radionuclides as adyuvant therapies for patients with metastasic disease from neuroendocrine tumors

      ea0022p400
    • Down-regulation of estrogen receptor- associates with transcriptional coregulator PATZ1 delocalization in human testicular seminomas

      ea0022p401
    • High prevalence of dopamine excess in patients with head and neck paragangliomas

      ea0022p402
    • Pheochromocytoma: seconds from disaster

      ea0022p403
    • Ectopic insulin secretion from distant metastasis or ectopic metaplasia after total pancreatectomy for ACTH-secreting endocrine pancreatic tumor revealing a Von Hippel Lindau disease

      ea0022p404
    • Cinacalcet hydrochloride effectively controlled primary hyperparathyroidism in patients unresponsive to bisphosphonates

      ea0022p405
    • Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients

      ea0022p406
    • Expression of Ki-67, RET and p53 in papillary thyroid microcarcinomas with or without autoimmune thyroid diseases

      ea0022p407
    • Familial acromegaly

      ea0022p408
    • Paraganglioma in a patient with atrophic gastritis

      ea0022p409
    • Evaluation of respiratory function in acromegalic patient

      ea0022p410
    • Single hospital experience of carcinoid tumours of colon and rectum

      ea0022p411
    • Long-term outcome of 65 patients with metastatic differentiated thyroid carcinoma

      ea0022p412
    • Von Hippel-Lindau disease: a case report

      ea0022p413
    • Natural history and clinical features of metastatic differentiated thyroid carcinoma

      ea0022p414
    • Atypical bronchopulmonary carcinoid tumor metastatic to endocrine glands and bone marrow

      ea0022p415
    • Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma characterized for plasma mitotane level and ERCC1 protein expression analyses

      ea0022p416
    • Rapid activation of cPLA2 induced by oestrogen in ER-positive and ER-negative breast cancer cell lines

      ea0022p417
    • Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

      ea0022p418
    • Erythropoietin levels in endocrinopathies

      ea0022p419
    • Prolactinoma registry- usefulness of a web tool

      ea0022p420
    • Thyroid Incidentaloma identified by 18F-Fluorodeoxyglucose Positron Emission Tomography with CT (FDG-PET/CT): clinical relevance

      ea0022p421
    • Juvenile hypertension due to coexistence of two very rare etiologies

      ea0022p422
    • Reversible heart failure after sorafenib administration in advanced metastatic differentiated thyroid carcinoma (DTC)

      ea0022p423
    • Serum concentration of o,p'DDD (mitotane), o,p'DDA and o,p'DDE as predictors of tumour response in adrenocortical carcinoma: results of a retrospective European Network for the Study of Adrenal Tumors (ENS@T) multicentre study

      ea0022p424
    • Clinical features and outcome of sporadic medullary thyroid carcinoma

      ea0022p425
    • Adrenocortical carcinoma (ACC): our experience

      ea0022p426
    • Polymorphisms in RET gene are associated with RET/PTC rearrangements in papillary thyroid carcinoma (PTC)

      ea0022p427
    • Malignant paraganglioma - the story of a long time survival

      ea0022p428
    • Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum

      ea0022p429
    • Intronic polymorphism IVS14-24G/A of the RET proto-oncogene seems to be protective for sporadic medullary thyroid carcinoma development

      ea0022p430
    • The Role of miRNA in reduction of type I 5'-iodothyronine deiodinase expression (D1) in renal clear cell carcinoma (ccRCC)

      ea0022p431
    • Unexplained hypoxemia in a patient with carcinoid syndrome

      ea0022p432
    • Pituitary adenoma mimicking a psychiatric disorder - a case report

      ea0022p433
    • Identification of hyperfunctioning parathyroids (HP) in primary hyperparathyroidism (pHPT) in the presence of concomitant thyroid diseases

      ea0022p434
    • Molecular analysis of tumor tissue enabled selection of a successful combined therapy of somatostatin and dopamine agonists in a case of TSH-secreting pituitary adenoma

      ea0022p435
    • Aryl hydrocarbon receptor- interacting protein: mutational analysis and functional validation in primary pituitary cell cultures

      ea0022p436
    • RET mutation screening in multiple endocrine neoplasia type 2 (MEN2) and medullary thyroid carcinoma patients (MTC) in Romania

      ea0022p437
    • Gonadotrophinoma and parathyroid adenoma

      ea0022p438
    • Cushing's syndrome, clinicaly non-functioning pituitary adenoma and hypercalcemia

      ea0022p439
    • Use of recombinant human thyroid-stimulating hormone (rhTSH) in children and adolescents with differentiated thyroid cancer

      ea0022p440
    • Metastatic mammary carcinomas with neuroendocrine features- a case report

      ea0022p441
    • The laterocervical unique masses - a challenging pathology

      ea0022p442
    • Is In2-ghrelin variant, a ghrelin gene derived transcript, a novel player in breast cancer tumors?

      ea0022p443
    • Gastroenteropatic Neuroendocrine tumors: multidisciplinary approach in therapy

      ea0022p444
    • The use of receptor tyrosine kinase inhibitors in metastatic differentiated thyroid carcinoma

      ea0022p445
    • The relationship of testosterone to PSA in men with sexual dysfunction

      ea0022p446
    • Primary carcinoid as an incidental finding in a mature cystic teratoma of the ovary: case report

      ea0022p447
    • Conditions and implications of rhTSH application for ablation in treatment of Differentiated thyroid cancer

      ea0022p448
    • Pheochromocytomas in the RET protooncogene mutations carriers

      ea0022p449
    • Unusual cause of hyercalcemia in pheochromocytoma

      ea0022p450
    • Prokineticin 1 stimulates prostate epithelial cell migration and proliferation in vitro

      ea0022p451
    • Cushing's disease as the first manifestation of familial multiple endocrine neoplasia syndrome type 1

      ea0022p452
    • Two exceptional etiologies of classic endocrinopathies

      ea0022p453
    • Peptide receptor radionuclide therapy and NETs: how to select patients?

      ea0022p454
    • Clinical characteristics of incidentally discovered phaeochromocytomas

      ea0022p455
    • The clonidine supression test with measurement of plasma metanephrines by enzyme immunoassay

      ea0022p456
    • Supradiaphragmatic ectopic ACTH: producing pituitary adenoma: a case report

      ea0022p457
  • Female reproduction
  • • GnRH test as an additional investigation in the diagnosis of polycystic ovary syndrome (PCOS): potential application of stimulated LH/FSH ratio

      ea0022p458
    • CAG repeat polymorphism in women with PCOS and healthy controls

      ea0022p459
    • CAG repeat polymorphism in healthy women

      ea0022p460
    • Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women

      ea0022p461
    • The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy postmenopausal women

      ea0022p462
    • Ethnic differences in manifestations of PCOS in 1010 Danish women

      ea0022p463
    • Kisspeptin levels in high risk pregnancies related to chronic diseases: insulin dependent diabetes mellitus (IDDM) and arterial hypertension (H)

      ea0022p464
    • Role of vitamin D treatment on metabolic and endocrine parameters in PCOS women

      ea0022p465
    • Serum soluble transferrin receptor (sTfR) concentrations and sTfR/ferritin ratio in premenopausal women: associations with glucose tolerance, insulin sensitivity and androgen excess

      ea0022p466
    • Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome

      ea0022p467
    • Familial occurrence of hormonal and metabolic abnormalities in first-degree relatives of women with PCOS

      ea0022p468
    • Chronic inflammation and Leu55Met PON1 polymorphism in polycystic ovary syndrome

      ea0022p469
    • Serum vaspin levels in women with polycystic ovaries and polycystic ovary syndrome

      ea0022p470
    • Characteristics secretion of melatonin at women with polycystic ovary syndrome

      ea0022p471
    • HPA axis function in obese women with PCOS

      ea0022p472
    • Metabolic syndrome indices and Framingham risk scoring in women with polycystic ovary syndrome

      ea0022p473
    • Serum ferritin in female-to-male transsexuals with polycystic ovary syndrome

      ea0022p474
    • Endothelial structure and function in young women with polycystic ovary syndrome: a 5 years follow-up study

      ea0022p475
    • Structured exercise training plus hypocaloric diet improves ovarian sensitivity to clomiphene citrate in polycystic ovary syndrome (PCOS) patients

      ea0022p476
    • An association between autoimmune thyroiditis and premature ovarian failure: a cross-sectional study

      ea0022p477
    • The polymorphic Alu1 variant of ER may modulate the feedback regulation of LH secretion

      ea0022p478
    • Expression of StAR protein and steroidogenic enzyme mRNAs in ovarian follicles of the domestic hen (Gallus gallus domesticus)

      ea0022p479
    • Endocrine safety of ulipristal acetate, a selective progesterone receptor modulator (SPRM): results from two phase II randomised, placebo-controlled studies

      ea0022p480
    • Serum concentrations of carboxylated osteocalcin are increased and associated with the components of the polycystic ovarian syndrome

      ea0022p481
    • Ascending aortic dilatation in Turner syndrome: the natural history

      ea0022p482
    • AMH secretion seems not to be influenced by acute GnRH-analogue administration in PCOS patients

      ea0022p483
    • Metabolic changes associated with hypogonadotropic hypogonadism in women of reproductive age and effect of HRT

      ea0022p484
    • The ovulatory capacity and related genes are altered in transgenic mice hypersecreting human chorionic gonadotrophin hormone (hCG)

      ea0022p485
    • The prevalence and phenotypes of polycystic ovary syndrome in Korean women

      ea0022p486
    • Hormonal correlates of different ejaculatory latencies in subjects with sexual dysfunction

      ea0022p487
    • Cardiovascular risk in lean algerian PCOS

      ea0022p488
    • Polymorphisms in the estrogen receptor gene and reproductive axis in women

      ea0022p489
    • Spontaneous pregnancy in Sheehan syndrome

      ea0022p490
    • Sheehan syndrome: metabolic and hormonal abnormalities (46 cases)

      ea0022p491
    • Progesterone receptor signaling: new tricks from an old dog

      ea0022p492
    • Inflammatory markers, adiponectin and metabolic characteristics in different phenotypes of polycystic ovary syndrome

      ea0022p493
    • Vitamin D levels in pregnant women in the city of Burgos (Spain)

      ea0022p494
    • The role of hyperprolactinemia in periductal and intraductal inflammation in mammary gland

      ea0022p495
    • The impact of the disease on life quality and health concept in young women with Turner's syndrome

      ea0022p496
    • The value of ovarian reserve markers in assisted reproductive technology

      ea0022p497
    • CAG repeat alleles of the androgen receptor are associated with polycystic ovary syndrome (PCOS) in the Romanian population

      ea0022p498
    • The unfavourable effect of oral contraceptive pills on the metabolic parameters in women with polycystic ovary syndrome

      ea0022p499
    • The effects of metformin therapy on hirsutism, androgen and metabolic parameters in PCOS women

      ea0022p500
    • Some subordinate steroid metabolites may better predict gestational age than the main pregnancy steroids

      ea0022p501
  • Growth factors
  • • Ghrelin (hunger hormone) and its effects on GH mean plasma concentration with different energy levels in camel

      ea0022p502
    • Acromegaly: a prospective analysis of the oral and maxillofacial pathologies and its impact of disease duration

      ea0022p503
    • Designing a long acting human GH by fusing the carboxyl-terminal peptide of human chorionic gonadotropin [beta] subunit to the coding sequence of human GH

      ea0022p504
    • Serum IGF1 levels in adult patients with type 1 Gaucher disease

      ea0022p505
    • Testicular TGF-[beta]1 system expression and its participation in hypertrophy and hyperplasia of Leydig cells

      ea0022p506
    • GH modulates migration of developing T cells

      ea0022p507
    • Insulin resistance induced by GH is transient and reversible: glucose clamp studies during different ambient GH levels in GH-deficient adults

      ea0022p508
    • Two years of GH therapy improves body composition in adults with Prader-Willi Syndrome

      ea0022p509
    • Growth failure in a girl harbouring digenic heterozygote mutations in the Ferroportin1-gene and the HFE-gene

      ea0022p510
    • IGF1 and IGFBP3 levels in relapsing-remitting and secondary progressive multiple sclerosis (MP)

      ea0022p511
    • Decreased expression of apoptotic genes in skeletal muscles, but not in hearts, of GH receptor knockout (GHRKO) mice

      ea0022p512
    • Overexpression of mRNA IGF1R during apoptosis in mice hepatic and cardiac cells

      ea0022p513
    • Statin modulation of growth factors in piglets with metabolic syndrome

      ea0022p514
    • Formation of neutralizing anti-human GH (hGH) antibodies does not explain the lack of IGF1 increase after recombinant hGH treatment in mice

      ea0022p515
    • The role of fibroblast grow factor 23 in vascular calcification

      ea0022p516
  • Male reproduction
  • • Gonadotrophins level in azoospermic patients in Plateau State

      ea0022p517
    • The case for comprehensive medical testing of gamete donors

      ea0022p518
    • Exogenous gangliosides modulate cellular free radical production

      ea0022p519
    • Regulation of sperm EGFR by ouabain leads to initiation of the acrosome reaction

      ea0022p520
    • Effect of melatonin in the phosphorylation of ERK42/44, P38 and JNK46/54, and the expression of c-jun and c-fos in hamster Leydig cells

      ea0022p521
    • Effect of prolactin (PRL) and melatonin (Mel) in the regulation of cyclooxygenase 2 (COX2) expression in Syrian hamster Leydig cells

      ea0022p522
    • The Moscow Study: a randomized, placebo-controlled, double-blind trial of parenteral testosterone undecanoate on the prostate status and blood count

      ea0022p523
    • Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome: the Moscow Study

      ea0022p524
    • Total but not calculated free testosterone concentration is lowered in young healthy South Asian men

      ea0022p525
    • Effects of atorvastatin on male fertility

      ea0022p526
    • Tadalafil attenuates proliferation and transdifferentiation of prostatic stromal cells indicating therapeutic potential for benign prostatic hyperplasia

      ea0022p527
    • Single nucleotide polymorphism (SNP) of endothelial nitric oxide synthase (eNOS) gene (GLU298ASP VARIANT) in infertile men with asthenozoospermia

      ea0022p528
    • Infertility and low gonadotropin levels as the first sign of testicular seminoma: a case report

      ea0022p529
    • Congenital hypogonadotropic hypogonadism in men as a cause of estradiol deficiency

      ea0022p530
    • Prevalence and characterization of hypogonadism among men with human immunodeficiency virus infection: preliminary results

      ea0022p531
    • Validation of salivary testosterone as a diagnostic test in the hypothalamic-pituitary-gonadal axis diseases

      ea0022p532
    • Determination of the reference values of total testosterone, calculated free testosterone, calculated bioavailable testosterone and salivary testosterone in young, healthy population of the Mediterranean area

      ea0022p533
    • Blood pressure control and endothelial funtion in type 2 diabetes: importance of nutritional educational program

      ea0022p534
    • Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome

      ea0022p535
    • Sexual dysfunctions in subjects with Klinefelter's syndrome

      ea0022p536
    • A case of partial androgen insensitivity syndrome with absence of breast development

      ea0022p537
    • Sexual and gonadal function in men after cardiac transplantation

      ea0022p538
    • Partial androgen insensitivity may be the reason for impaired fertility in men with Noonan Syndrome

      ea0022p539
    • Can high radioactive contamination possibly influence frequency of androgen receptor mutation?

      ea0022p540
    • The effect of undecanoat testosterone depot on the prostate volume

      ea0022p541
    • Initial characterization of the human seminal plasma proteome in a fertile normogonadic man by top-down strategy

      ea0022p542
    • Serum INSL3 dynamics in young men with congenital hypogonadotropic hypogonadism treated with gonadotropins

      ea0022p543
    • Testosterone replacement therapy isn't always contraindicated after prostate cancer treatment: case report

      ea0022p544
  • Neuroendocrinology and Pituitary (Generously supported by Novartis)
  • • Prothrombin time, activated thromboplastin time, fibrinogen, and D-dimer levels, and von Willebrand activity of patients with Sheehan's syndrome and the effect of hormone replacement therapy

      ea0022p545
    • Plasma agouti-related peptide (AgRP) levels in male patients with hypogonadotropic hypogonadism

      ea0022p546
    • Ghrelin and leptin levels in acromegalic patients treated with pegvisomant

      ea0022p547
    • Evaluation of adrenal morphological and functional alterations in acromegalic patients

      ea0022p548
    • IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly

      ea0022p549
    • Angiotensin converting enzyme I/D and M235T angiotensinogen gene polymorphism in patients with acromegaly

      ea0022p550
    • Combined endoscopic and pharmacologic treatment of a suprasellar arachnoid cyst associated with macroprolactinoma

      ea0022p551
    • Incidentally found nonfunctioning pituitary macroadenomas: should we suspect them earlier?

      ea0022p552
    • Efficacy of acromegaly treatment in six Czech and Slovak tertiary centers: first analysis of patient registry RESET (Registry of Sellar Tumors)

      ea0022p553
    • Increased prevalence of psychopathology and maladaptive personality traits in patients after long-term cure of Cushing's disease

      ea0022p554
    • Negative magnetic resonance imaging in Cushing's disease

      ea0022p555
    • Development of a new questionnaire for evaluating QOL in adult hypopituitarism: adult hypopituitarism questionnaire (AHQ)

      ea0022p556
    • Plasma ghrelin concentrations in narcoleptic patients

      ea0022p557
    • Clinically silent pituitary macroadenomas: a clinicopathologic analysis

      ea0022p558
    • Hormonal and non-hormonal factors contributing to chronic fatigue in traumatic brain injury patients

      ea0022p559
    • Management of patients with childhood onset GH deficiency (COGHD) in the transition phase

      ea0022p560
    • The diagnosis of GH deficiency in obese patients: what help from pharmacological blockade of lipolysis?

      ea0022p561
    • Assessment of biochemical control of acromegaly during treatment with somatostatin analogues: is there still a role for glucose oral load?

      ea0022p562
    • Influence of psychological variables on partially and fully recovering in patients with anorexia nervosa

      ea0022p563
    • Use of cabergolin in Nelson's syndrome: preliminary results in four patients

      ea0022p564
    • Daily temozolomide therapy in Nelson's syndrome

      ea0022p565
    • Euthyroidism and tumor stability achieved in a TSH-secreting pituitary macroadenoma treated with octreotide-LAR and cabergoline: case report and literature review

      ea0022p566
    • Effects of GH replacement therapy on hematopoiesis and immune function: a placebo controlled study

      ea0022p567
    • Comparison of 1 [mu]g ACTH, 250 [mu]g ACTH and glucagon tests for assessment of the hypothalamo-pituitary-adrenal axis in healthy subjects

      ea0022p568
    • Unsatisfied treatment outcomes of acromegaly patients: a single center experience in Turkey

      ea0022p569
    • The presentation of sellar and parasellar tumours in Uzbekistan

      ea0022p570
    • Long-term morbidities in patients with Cushing's disease

      ea0022p571
    • Comparison of different therapy approaches in acromegaly

      ea0022p572
    • Clinical and epidemiologic features of acromegaly in the Republic of Uzbekistan

      ea0022p573
    • Frequency of neuroendocrinal disturbances in patients with different pituitary adenomas

      ea0022p574
    • Frequency of a postoperational hypopituitarism in patients with pituitary tumors after transnasal hypophysectomies

      ea0022p575
    • Manifestation factors of the disease and complications rate in patients with acromegaly from Aral Sea regions of the Republic of Uzbekistan

      ea0022p576
    • Pneumocystis pneumonia during conservative treatment of Cushing's syndrome: description of two cases

      ea0022p577
    • Use of the desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing's disease

      ea0022p578
    • The prognostic criteria for the efficiency of the long-termed administration of somatostatin analogues

      ea0022p579
    • Incidence and dynamics of visual disturbances in hypothalamus and pituitary mass lesions after transphenoidal surgery in the Republic of Uzbekistan

      ea0022p580
    • The rate of vascular complications in acromegaly in the Republic of Uzbekistan

      ea0022p581
    • Long and short-term therapy effectiveness with dopamine agonists in acromegaly in the Republic of Uzbekistan

      ea0022p582
    • Plasma asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine levels in patients with active acromegaly

      ea0022p583
    • Heparanase is highly expressed in GH-adenomas and regulates proliferation of pituitary tumor cells

      ea0022p584
    • The metabolic syndrome (MetS) in 2610 GH deficient (GHD) subjects before GH replacement: a KIMS (Pfizer International Metabolic Database) analysis

      ea0022p585
    • Effect of octreotide LAR on the volume of pituitary adenoma in acromegalic patients

      ea0022p586
    • Evaluation of efficacy of somatostatin analogue octreotide LAR in acromegalic patients following non-radical surgery of pituitary adenoma

      ea0022p587
    • Prospective evaluation of traumatic brain injury mediated hypopituitarism 1 year after the event

      ea0022p588
    • The influence of the successful treatment of acromegaly on tissue distribution and overall BMD

      ea0022p589
    • Sleeping apnea syndrome (SAS) in acromegaly and obesity

      ea0022p590
    • The effect of gonadal replacement on insulin resistance in hypogonadal adult men with GH deficiency

      ea0022p591
    • The anorexigenic neuropeptide, NUCB2/nesfatin-1, is indispensable for normal puberty onset in the female rat

      ea0022p592
    • Investigation of skin characteristics in patients with acromegaly

      ea0022p593
    • Efficacy and safety of combined treatment with somatostatin analogues (SA) AND pegvisomant (PEG) in acromegalic patients resistant to SA

      ea0022p594
    • Pituitary functions in patients with chronic subdural hematoma

      ea0022p595
    • Comparison of the efficacy of GH therapy in short children with decreased nocturnal GH secretion and either normal or subnormal results of GH stimulating tests

      ea0022p596
    • Contribution of the molecular biology to the study of the behaviour of pituitary adenomas

      ea0022p597
    • The occurrence of hypothyroidism during the initial phase of GH replacement therapy in children with GH deficiency: clinical implications

      ea0022p598
    • The prothrombotic state in patients with Cushing's disease

      ea0022p599
    • Usefulness of cabergoline determination by mass spectrometry during prolactinoma treatment

      ea0022p600
    • Basal and stimulated GH secretion in Cushing's syndrome: effects of ghrelin and GHRH+arginine

      ea0022p601
    • Application of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas

      ea0022p602
    • Adrenalectomy (ADX) increases the activation of hypothalamic and nucleus of the solitary tract (NTS) neurons related with food intake control during endotoxemia

      ea0022p603
    • CB1 modulation of hormone secretion, neuronal activation and mRNA expression following blood volume expansion (BVE)

      ea0022p604
    • The regulation of the hypothalamic-pituitary axis is altered in transgenic male mice overexpressing human chorionic gonadotrophin (hCG)

      ea0022p605
    • Impact of rosiglitazone on serum IGF1 concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study

      ea0022p606
    • Quality of life after multimodality treatment of acromegaly

      ea0022p607
    • Epidemiology and outcomes after multimodality therapy of acromegaly over three decades in the Maltese population

      ea0022p608
    • An adult patient with ectopic neurohypophysitis and panhypopituitarism due to absent pituitary stalk

      ea0022p609
    • Presentation, treatment and outcomes in patients with non-functioning pituitary adenomas (NFPA) in Malta

      ea0022p610
    • Plasma levels of adiponectine and nutritional status in patients affected by anorexia Nervosa

      ea0022p611
    • The predictors of the response to somatostatin analogue therapy in patients with acromegaly

      ea0022p612
    • Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma

      ea0022p613
    • Risk factors for development of atherosclerosis in young women with hyperprolatinemia

      ea0022p614
    • Lanreotide-ATG effectiveness on tumoral mass shrinkage of two thyrotropin-secreting pituitary macroadenomas

      ea0022p615
    • Pain characteristics in patients with Cushing's disease compared to patients with non-functioning pituitary adenomas

      ea0022p616
    • Epidemiology of craniopharyngioma in Denmark 1985-2004: a 2% increase in incidence rate per year

      ea0022p617
    • Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood

      ea0022p618
    • Lymphocytic hypophysitis: clinical characteristics and endocrine features of 64 GH deficient patients in KIMS: Pfizer International Metabolic Database

      ea0022p619
    • Epidemiology of acromegaly in Italy

      ea0022p620
    • Decreased cortical thickness on MRI in patients with Cushing's syndrome: preliminary experience

      ea0022p621
    • Patients with prolactinomas exhibit distinct personality patterns: comparison of 84 prolactinoma patients with 58 patients with non-functioning pituitary adenomas and 168 age- and gender-matched controls

      ea0022p622
    • Circadian rhythmicity changes of gonadal and growth axis in adolescent idiopathic scoliosis

      ea0022p623
    • Ultrasound-assisted microsurgery for pituitary macroadenomas

      ea0022p624
    • Efficacy and safety of co-administration of lanreotide Autogel 120 mg monthly with pegvisomant weekly in patients with acromegaly partially controlled by somatostatin analogues

      ea0022p625
    • Longitudinal combined evaluation of antipituitary antibody titer and immunofluorescence pattern is a suitable tool in predicting autoimmune hypophysitis in patients with autoimmune polyendocrine syndromes

      ea0022p626
    • Pituitary surgery for Cushing's disease: the use of per-operative ACTH sampling

      ea0022p627
    • Evaluation of the relationship between macroprolactin levels and clinical and radiological findings in patients with hyperprolactinemia

      ea0022p628
    • Flexion contractures syndrome as the initial manifestation of hypopiptuitarism

      ea0022p629
    • Outcome of patients with diabetes insipidus associated with adipsia

      ea0022p630
    • Correlation between GH and FSH in the cerebrospinal fluid and sleep respiratory events

      ea0022p631
    • Modification of epicardial fat thickness in adult GHD patients after short-term replacement therapy with rhGH

      ea0022p632
    • Relationship between metabolic parameters and central dopaminergic activity in healthy men

      ea0022p633
    • Results of French collaborative evaluation (DEPHY-TC) in patients with suspected pituitary abnormalities after traumatic brain injury (TBI)

      ea0022p634
    • A case of lymphocytic panhypophysitis

      ea0022p635
    • Evaluation of quality of life in patients with acromegaly using the acromegaly quality of life questionnaire (AcroQoL)

      ea0022p636
    • Rapid bone loss 23 years after diagnosis for childhood acute lymfoblastic leukaemia (ALL) in spite of GH therapy

      ea0022p637
    • Effects on glucose metabolism of high-dose octreotide LAR in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy

      ea0022p638
    • Sub-acute tumour debulking with somatostatin analogues in newly diagnosed acromegaly due to macroadenomas

      ea0022p639
    • Long-term treatment of Cushing's disease with pasireotide (SOM230): results from a Phase II extension study

      ea0022p640
    • Heterogeneous origin of idiopathic isolated central hypothyroidism

      ea0022p641
    • Echocardiographic assessment of cardiac valves morphology and function in patients with prolactinomas under long-term treatment with cabergoline or bromocriptine

      ea0022p642
    • The effect of GH on rat neurogenesis in the dentate gyrus of hypocampus

      ea0022p643
    • Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study

      ea0022p644
    • Long-term treatment of acromegaly with pasireotide (SOM230): results from a Phase II extension study

      ea0022p645
    • Growth modelling of non-functioning pituitary adenomas

      ea0022p646
    • A case of empty sella turcica and Cushing's disease

      ea0022p647
    • Reproductive changes in females with 'empty sella' syndrome

      ea0022p648
    • Aftercare in patients with Cushing's disease and acromegaly: is there room for improvement?

      ea0022p649
    • Persistent hypocortisolism in Cushing's disease and persistent comorbidities in acromegaly determine neurocognitive function and quality of life after surgical treatment

      ea0022p650
    • Demographic factors and the presence of comorbidities do not promote early detection of Cushing's disease and acromegaly

      ea0022p651
    • A case of giant prolactinoma in a 14-year old boy

      ea0022p652
    • Leptin receptor gene expression and its promoter methylation do not change with age in peripheral blood mononuclear cells

      ea0022p653
    • Presence of kiss1/kiss1r system at the pituitary, testis and adipose tissue in rodents: functional actions and regulation by physiological cues

      ea0022p654
    • Kisspeptin selectively increases LH and GH, but not FSH, ACTH, PRL or TSH, release in primary pituitary cell cultures from a non-human primate (Papio anubis) via distinct signaling pathways and under influence of sex steroids

      ea0022p655
    • Diabetes Mellitus influence on GH and IGF-1 levels in acromegalic patients

      ea0022p656
    • Cabergoline treatment in Cushing's disease: effect of cabergoline withdrawal in patients with normalized cortisol secretion after long-term treatment

      ea0022p657
    • Carbohydrate disorders in patients with acromegaly

      ea0022p658
    • Study of pituitary function in acromegaloidism

      ea0022p659
    • Trends in acromegaly treatment in Spain

      ea0022p660
    • SSTR5 ligand binding domain immunohistological detection in pituitary adenomas using Y-SSTR5 a new mouse monoclonal antibody

      ea0022p661
    • Acromegaloidism: description of fifteen cases

      ea0022p662
    • Sellar lesions in Ollier disease: case report and a review of the literature

      ea0022p663
    • Comparison of efficacy of cabergoline and bromocriptine retrospectively in patients with hyperprolactinemia

      ea0022p664
    • Transition from Cushing's disease to a hormonally inactive adenoma or vice versa: four unusual cases of corticotroph adenoma

      ea0022p665
    • comparison of octreotide LAR and lanreotide autogel treatments in post-operative medical treatment of acromegaly

      ea0022p666
    • FSH-staining pituitary adenomas: a review of 37 cases

      ea0022p667
    • IGF1 levels as predictor factor of metabolic derangement in adult patients with severe GH deficiency

      ea0022p668
    • Hypertension as the first and for long time period the only sign of ACTH producing pituitary adenoma: A case report

      ea0022p669
  • Obesity
  • • Impact of sarcopenia on metabolic profile in sarcopenic-obese post menopausal women?

      ea0022p670
    • Metabolic surgery (gastric bypass) has no 'magical effect' in severely obese patients with type 1 diabetes

      ea0022p671
    • Testosterone gel significantly increase lean body mass in ageing males with relatively low bio-available testosterone and waist circumference above 94 cm: a double blinded, randomized, placebo controlled 6 months study

      ea0022p672
    • Ghrelin basal levels in people with abdominal obesity

      ea0022p673
    • Osteocalcin and the metabolic syndrome

      ea0022p674
    • Relationship between obesity and classic cardiovascular risk factors

      ea0022p675
    • Pathological types of the family education as the risk factor of the childhood obesity

      ea0022p676
    • TSH levels in overweight and obese euthyroid subjects with metabolic syndrome

      ea0022p677
    • Complementary and alternative treatment approaches in obese patients: a cross-sectional study

      ea0022p678
    • Differential expression of proteins in omental and subcutaneous adipose tissue

      ea0022p679
    • Relationship between the breast cancer and abdominal obesity

      ea0022p680
    • The Moscow study: a randomized, placebo-controlled, double-blind trial of parenteral testosterone undecanoate on the metabolic syndrome components and body composition

      ea0022p681
    • Effects of parenteral testosterone undecanoate administration on inflammatory markers: the Moscow study

      ea0022p682
    • Visceral fat accumulation as a risk factor for the carotid plaque occurrence in ischemic stroke patients

      ea0022p683
    • Relation of PPAR[gamma] genetic polymorphism and testosterone levels in males with metabolic syndrome

      ea0022p684
    • The effects of orlistat on weight, serum lipids, blood pressure and fasting plasma glucose in obese patients with prediabetes

      ea0022p685
    • Increased oxidative damage to lipids and DNA in overweight and obese patients

      ea0022p686
    • Glucagon stimulates cholecystokinin secretion in humans

      ea0022p687
    • Early genetic rescue of extremely obese POMC-deficient mice is critical for successful recovery of normal feeding behavior and body weight

      ea0022p688
    • Influence of age of onset of metabolic syndrome

      ea0022p689
    • Serum fibroblast growth factor 21 in human obesity: regulation by hyperinsulinemia and relationship with glucose and lipid oxidation

      ea0022p690
    • Predictive factors for a good response to antidepressant pharmacotherapy in patients with metabolic syndrome

      ea0022p691
    • Assessment of correlations between IL-18, CRP and selected adrenal androgens serum levels according to the anthropometrical and biochemical indices of metabolic syndrome (MS) in ageing men

      ea0022p692
    • The obese phenotype is associated with more severe autoimmune thyroiditis evolving towards primary hypothyroidism

      ea0022p693
    • Reference interval values of four plasmatic endocannabinoids measured by isotopic dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)

      ea0022p694
    • The metabolic syndrome and the non-alcoholic fatty liver disease: metabolic and pathology aspects

      ea0022p695
    • Obesogenic environmental risk factors in Belarusian preschool children

      ea0022p696
    • Waist circumference does not reflect body fat distribution and insulin resistance in young male patients with idiopathic hypogonadotrophic hypogonadism

      ea0022p697
    • Abdominal fat, insulin sensitivity, inflammatory atheromatosis risk factors and polymorphisms of 174-G/C IL-6 promoter and Pro12Ala PPAR[gamma] in non-obese subjects

      ea0022p698
    • FTO gene haplotypes are associated with GH levels in lean women

      ea0022p699
    • Obesity and malnutrition are associated with different inflammation patterns in rats

      ea0022p700
    • The circulating pattern of adiponectin and resistin in critically ill patients with sepsis

      ea0022p701
    • Acylated, unacylated ghrelin and obestatin regulation during oral glucose tolerance test in obese prepubertal and pubertal children

      ea0022p702
    • Melanocortin-4 receptor gene polymorphism (rs12970134) influences glucose metabolism, leptin and GH levels in women

      ea0022p703
    • Vitamin D levels in obese patients with and without metabolic syndrome

      ea0022p704
    • Relation of waist line radius and subcutaneous adipose tissue thickness positively correlates with markers of impaired glycemic control

      ea0022p705
    • The influence of weight-loss induced by bariatric surgery on serum concentrations of novel metabolic regulators FGF-21 and FGF-19 in morbidly obese subjects

      ea0022p706
    • Complementary and alternative medicine use in patients with obesity: an anthropological approach

      ea0022p707
    • Prevalence of no insulin-resistance in morbidly obese patients

      ea0022p708
    • Influence of metformin therapy on peripheral blood androgenes concentrations in young women with metabolic syndrome

      ea0022p709
    • Sideways in treatment of obese child: a personal experience

      ea0022p710
    • Limited weight loss with gastric banding in patients with craniopharyngeoma

      ea0022p711
    • Desacyl-ghrelin as a protective factor for obesity

      ea0022p712
    • Gastric inhibitory polypeptide (GIP) suppresses circulating ghrelin in humans: plasma metabolome based correlation network analysis for support of hormone-to- hormone interactions

      ea0022p713
    • Effects of breastfeeding on maternal appetite-regulating hormones

      ea0022p714
    • Relation of weight, height and BMI of child to parental characteristics in families with obese or overweight parents before weight management: diogenes project

      ea0022p715
    • Childhood obesity surveillance initiative in the Czech Republic: the association between BMI and school environment

      ea0022p716
    • Characterisation of serum and glucocorticoid-induced kinase 1 in adipose tissue

      ea0022p717
    • Carbohydrate metabolism in obese women: association with the circulating levels of adiponectin and retinol binding protein-4

      ea0022p718
    • Lindaxa effectiveness in obesity treatment associated with IGT and arterial hypertension

      ea0022p719
  • Signal transduction
  • • Role of filamin-A in the regulation of dopamine D2 receptor localization and signaling in a lactotroph cell model

      ea0022p720
    • Lysyl oxidase interacts with AGEs signaling to modulate collagen synthesis in polycystic ovarian tissue

      ea0022p721
    • Peroxisome-proliferator-activated receptor gamma is required for modulating endothelial inflammatory response through a novel nongenomic mechanism

      ea0022p722
    • The subunits of heterotrimeric G-protein in thyroid plasma membranes

      ea0022p723
    • Spatial and temporal regulations of MAPKinases ERK1/2 in the somatolactotroph cell line GH4C1

      ea0022p724
    • Molecular origin of idiopathic central hypogonadism: variable impairment of two signal-transduction pathways due to PROKR2 mutations

      ea0022p725
  • Steroid metabolism & action
  • • Rapid non-genomic effects of cortisol on glucose-induced insulin secretion in humans

      ea0022p726
    • The response of creatine kinase specific activity in rat pituitary to estrogenic compounds and vitamin D less- calcemic analogs

      ea0022p727
    • Association of vitamin D status with serum androgen levels in men

      ea0022p728
    • Testosterone levels in acute exacerbation of chronic obstructive pulmonary disease: relationship with severity indices

      ea0022p729
    • Prospective association of low total testosterone levels with adverse lipid profile and incident dyslipidemia: results from the study of health in Pomerania

      ea0022p730
    • The relationship between aortic stiffness and left ventricular function in patients with Cushing's disease

      ea0022p731
    • Influence of steroid hormones on anthropometric parameters in men

      ea0022p732
    • Aldosterone-induced epithelial sodium channel (ENaC) expression and trafficking is regulated by protein kinase D1 in M1 renal cortical collecting duct cells

      ea0022p733
    • Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects

      ea0022p734
    • Effect of body mass index on differences of sex hormone levels in postmenopausal women receiving low-dose hormone therapy

      ea0022p735
    • Measurement of testosterone in muscle tissue using microdialysis: preliminary data

      ea0022p736
    • Expression and biological function of sex steroid receptors in male human bladder

      ea0022p737
    • Androgenicity is enhanced in the presence of ala222val polymorphism in healthy postmenopausal women

      ea0022p738
    • Synthesis of 1,25-dihydroxyvitamin D in human bladder epithelial cells and vitamin D mediated cathelicidin induction

      ea0022p739
    • Simultaneous steroid measurement by isotopic dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS): comparison with routine analysis methods and reference intervals in normal subjects

      ea0022p740
    • Sex specific association between estrogen receptor alpha PvuII and XbaI gene polymorphisms and hormones

      ea0022p741
    • Tissue expression of the CYP19A1 gene and aromatase protein in male cynomolgus monkeys (Macaca fascicularis)

      ea0022p742
    • Levels of 7-hydroxy DHEA derivates during menstrual cycle

      ea0022p743
    • Sex steroid status in relation to birth weight and body composition in young healthy men

      ea0022p744
  • Thyroid
  • • Effectiveness of consevator treatment (antithyroidiennes and thyroxine) on the autonomous nodule, toxic adenoma, and Plummer's disease (multinodular hyperthyroideous Goiter)

      ea0022p745
    • Pheochromocytoma, papillary thyroid carcinoma: new entity

      ea0022p746
    • Outcome of pregnancy complicated by thyroid dysfunction in Iran

      ea0022p747
    • Detection of BRAF gene mutation in preoperative diagnostic of thyroid gland cancer

      ea0022p748
    • Evaluation of diagnostic utility of Galectin-3 protein detection in preoperative diagnostic of high-differentiated thyroid gland cancer by flow cytometry method

      ea0022p749
    • Promoter methylation of gelsolin gene in thyroid cancer

      ea0022p750
    • Role of hypothyroidism in predicting a worse prognosis of heart failure outpatients treated with amiodarone

      ea0022p751
    • Results from an observational study on general practitioners' and endocrinologists' medical practice for the management of simple goiter in France

      ea0022p752
    • The effect of urine iodine excretion in patients with euthyroid noduler disease: a randomised, controlled study

      ea0022p753
    • Carotid intima media thickness increased similarly in subclinical hypothyroidism and clinical hypothyroidism

      ea0022p754
    • Realtime elastography for the differentiation of benign and malignant thyroid nodules: a meta-analysis

      ea0022p755
    • Have the hypothyroid patients really had 'euthyroid' quality of life after the euthyroid state is established with levothyroxine-substitution?

      ea0022p756
    • Histological results in the cases of thyroid cytology indeterminate or suspicious for malignancy

      ea0022p757
    • Increased frequency of the glucocorticoid receptor gene polymorphisms in patients with autoimmune thyroid diseases

      ea0022p758
    • Expressions of vascular endothelial growth factor (VEGF), VEGF receptor 1 (VEGF1), insulin like growth factor 1 (IGF1) and IGF1 receptor in differentiated thyroid carcinoma

      ea0022p759
    • Follicular tumour in fine needle aspiration byopsy of thyroid: predictive factors of mallignancy

      ea0022p760
    • Crescent incidence of papillary thyroid microcarcinoma: 2000--09

      ea0022p761
    • An increase in serum CA 19-9 leading to the discovery of thyroid cancer in patient with the history of rectosigmoid cancer

      ea0022p762
    • Effect of hyperthyroidism on parameters of oxidative stress and antioxidant status in Wistar rats

      ea0022p763
    • Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor

      ea0022p764
    • Amiodarone-induced thyrotoxicosis in patients with multinodular goiter: type 1 or type 2 AIT?

      ea0022p765
    • Deiodinase impairment in the autoimmune thyroid disease: case report

      ea0022p766
    • Panobinostat restores iodine uptake in primary cultures of undifferentiated thyroid tumours

      ea0022p767
    • Nodular goiter and its natural selection in modern terms

      ea0022p768
    • Thyroid metastases due to lung adenocarcinoma

      ea0022p769
    • The evaluation of some severity and activity parameters in Graves' ophthalmopathy

      ea0022p770
    • High fT3 (free triiodothyronine), new syndrome or innocent bystandar

      ea0022p771
    • Vitamin D deficiency contributes to post-thyroidectomy hypocalcemia

      ea0022p772
    • Antenatal thyroid function and postpartum mood disturbances

      ea0022p773
    • The evidence of TSH variation according to the temperature and geographic region in patients with thyroid pathology

      ea0022p774
    • Insulin resistance, lipid profile, C-reactive protein and homocysteine in patients with autoimmune thyroiditis and subclinical hypothyroidism

      ea0022p775
    • Thyrotoxic normokalemic periodic paralysis: a case report

      ea0022p776
    • Simple clinical and paraclinical factors may predict outcome of treatment for Graves' hyperthyroidism

      ea0022p777
    • Clinical and histological different features in the form of presentation between papillary microcarcinomas and papillary carcinomas of larger size

      ea0022p778
    • Selenium serum levels in patients with mild Graves' orbitopathy: results of a controlled study

      ea0022p779
    • The serum C-reactive proteine in dysthyreosis

      ea0022p780
    • Coagulation disorders in hypothyroidism: effects of thyroid hormones deficiency and/or of TSH?

      ea0022p781
    • Mild hypothyroidism in young patients with congenital heart defects: association with 22q11.2 microdeletion

      ea0022p782
    • Changing trends in the incidence of thyroid carcinoma in a single clinical centre

      ea0022p783
    • Beverage iodine levels in Germany

      ea0022p784
    • Urinary iodide excretion in adults in Germany 2005 meets WHO target

      ea0022p785
    • Effect of pentoxifylline and glucocorticoids on peripheral blood mononuclear cells proliferation and apoptosis in Graves' ophthalmopathy

      ea0022p786
    • Serum levels of antibodies to thyroid peroxidase in women after miscarriages in comparison with the 1st trimester of pregnancy and healthy non-pregnant women

      ea0022p787
    • Role of calcitonin (Ct) in wash-out fluid from fine-needle aspiration (FNAB) in the diagnosis of medullary thyroid cancer (MTC): comparison with basal calcitonin, cytology and pentagastrin stimulation test (Pg-Test)

      ea0022p788
    • BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules

      ea0022p789
    • Diagnosing a cribriform papillary thyroid cancer in a patient with familial adenomatous polyposis

      ea0022p790
    • Is there a relationship between colonic polyps and thyroid nodules?

      ea0022p791
    • Improving the accuracy of clinical diagnosis in hyperthyroid disorders using ultrasound assessment

      ea0022p792
    • Differences in Graves' orbitopathy between hyperthyroid and hypothyroid/euthyroid patients

      ea0022p793
    • Prevalence of undiagnosed thyroid disease in pregnancy

      ea0022p794
    • Parvovirus B19 infection: a possible role in autoimmune thyroid diseases

      ea0022p795
    • Echocardiographyc features in resistance to thyroid hormone

      ea0022p796
    • Reversible thyrotoxic cardiomyopathy

      ea0022p797
    • Usefulness of sorafenib in the management of advanced thyroid carcinoma

      ea0022p798
    • Therapeutic effect of sesame oil on monosodium urate monohydrate crystal-induced acute inflammation in rat air pouches

      ea0022p799
    • CTLA-4 -1661A/G and -658C/T gene polymorphisms in autoimmune thyroid diseases

      ea0022p800
    • Cytokine profile in Graves' ophthalmopathy patients

      ea0022p801
    • Predictors of cardiovascular risk in patients with hyperthyroidism before and after radioiodine therapy

      ea0022p802
    • Thyroid lymphoma: a rare pathology: study on 9 cases

      ea0022p803
    • Ultrasound fine needle aspiration (US - FNA) in an Endocrinology Department: our reality and results quality

      ea0022p804
    • Cytologic comparison between growing and non-growing benign thyroid nodules evaluated using two different growth criteria

      ea0022p805
    • Scintigraphy 131I-mIBG in patient with positive ret germline mutation for medullary thyroid carcinoma

      ea0022p806
    • Cytologic results of thyroid fine needle aspiration biopsy from geriatric patients; A single centre experience

      ea0022p807
    • Thyroid hormones regulate the production of complement mannan-binding lectin regardless of the MBL2 genotype: a cohort study of 95 patients with autoimmune thyroid disorders.

      ea0022p808
    • Pitfalls in calcitonin measurement: case report

      ea0022p809
    • Atorvastatin inhibited proliferation in papillary thyroid cancer cell line

      ea0022p810
    • Reference interval of TSH in the first trimester of pregnancy and its relationship to further thyroid examinations

      ea0022p811
    • Analytical performances and reference ranges of new ultrasensitive TSH and free thyroxine assays on the ADVIA Centaur[reg] Immunoassay Systems

      ea0022p812
    • Association of Pro[12]Ala PPAR-[gamma] gene polymorphism with Graves' orbitopathy

      ea0022p813
    • Age and size of goitre in hyperthyroidism

      ea0022p814
    • Evaluation of theurapeutic modalities in Graves' hyperthyroidism

      ea0022p815
    • A single small dose of rituximab may be effective in Graves' orbitopathy

      ea0022p816
    • Nonthyroidal illness in pregnancy

      ea0022p817
    • Long-term results of selective thyroid surgery for benign nodular goiter (BNG)

      ea0022p818
    • Haemorheopheresis in the treatment of Graves' ophtalmopathy: A randomized study

      ea0022p819
    • Rapid solid-phase-extraction for the quantitative analysis of serum iodothyronine profiles

      ea0022p820
    • Long term results of Isthmus preserving total bilobectomy (IPTB) as the optimized treatment for C-cell hyperplasia

      ea0022p821
    • Thyroid function and autoimmunity in [beta]-Thalassemia ([beta]-Thal)

      ea0022p822
    • DNA repair genes in the thyroid cell lines and human tumors

      ea0022p823
    • Evaluation of interrelationships between thyroid function, insulin resistance, lipid profile and inflammation in autoimmune thyroiditis

      ea0022p824
    • Effects of hyperthyroidism, hypothyroidism and thyroid autoimmunity on female sexual function

      ea0022p825
    • Evaluation of interrelationships between thyroid function, lipid profile, homocysteine and high sensitivity C-reactive protein in patients with autoimmune thyroiditis

      ea0022p826
    • Cito-histologycal correlations in nodular thyroid pathology

      ea0022p827
    • Prognostic value of recombinant TSH-stimulated thyroglobulin determination in follow-up of differentiated thyroid cancer

      ea0022p828
    • Metastasis in differentiated carcinomas of the thyroid

      ea0022p829
    • TSH receptor antibody levels (TSHAb) in hyperthyroid patients with Graves' disease (GD): an evaluation of the outcome of 131I therapy

      ea0022p830
    • A difficult case of the medullary thyroid cancer

      ea0022p831
    • Scarless neck by conducting robot-assisted thyroidectomy: our initial experience

      ea0022p832
    • Is there a need to constitute laboratory- and/or region-specific reference ranges for the screening of thyroid disorders?

      ea0022p833
    • The accuracy of fine needle aspiration cytology in the tryroid nodule study, in a tertiary hospital

      ea0022p834
    • Hypothyroidism related to tyrosine kinase inhibitors: an underdiagnosed disorder?

      ea0022p835
    • Procalcitonin: a promising role in medullary thyroid carcinoma?

      ea0022p836
    • Prevalence of associated thyroid pathologies in patients with thyroid hemiagenesis and normally developed thyroid gland

      ea0022p837
    • Simultaneous thyroid and gastric autoimmune disease: clinical aspects of 78 cases

      ea0022p838
    • FOXE1 polyalanine tract (FOXE1-polyA) length polymorphism in patients with thyroid hemiagenesis and subjects with normal thyroid

      ea0022p839
    • Isolated maternal hypothyroxinemia in women with gestational diabetes mellitus and its connection to necessity of insulinotherapy

      ea0022p840
    • Effects of rhTSH administration on 24 h arterial pressure in subjects undergoing evaluation for differentiated thyroid cancer

      ea0022p841
    • The association of autonomous thyroid functional nodules with autoimmune thyroid disease

      ea0022p842
    • Effects of L-thyroxine treatment on resistin and high-sensitive CRP levels in patients with subclinical hypothyroidism

      ea0022p843
    • The predictive value of ultrasonography in detection of autoimmune thyroiditis

      ea0022p844
    • Fine needle aspiration biopsy of a thyroid nodule: a comparison of diagnostic performance of experienced and inexperienced physicians

      ea0022p845
    • Limited therapeutically options in a case of invasive papillary thyroid carcinoma

      ea0022p846
    • Prevalence of benign breast diseases in nodular goiter and autoimmune thyroid diseases

      ea0022p847
    • Angiogenesis: the new orientation in medullary thyroid carcinoma

      ea0022p848
    • The thyroid volume reference values for Polish children

      ea0022p849
    • Lp(A) levels in thyroid disfunctions

      ea0022p850
    • Drug induced hyperthyroidism (a rare reaction of sorafenib): case report

      ea0022p851
    • Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area

      ea0022p852
    • Marked sensitivity of pituitary feedback to levothyroxine in asymptomatic primary autoimmune hypothyroidism

      ea0022p853
    • Differentiated thyroid carcinoma in young adults

      ea0022p854
    • Molecular classification of benign and malignant thyroid nodules

      ea0022p855
    • The limitations of thyroid volume reference values in assessment of iodine nutrition after recent introduction of iodine prophylaxis

      ea0022p856
    • A study of thyroid disorders in pregnancy

      ea0022p857
    • The evaluation of radioiodine therapy out come after five years in patient with subclinical hyperthyroidism

      ea0022p858
    • The influence of radioiodine therapy on some parameters of oxidant/antioxidant balance in patients with Graves' disease

      ea0022p859
    • Thyroid incidentaloma: palpable problems of an impalpable nodule

      ea0022p860
    • Elastography based on tissue Doppler in the diagnosis of thyroid nodules: a pilot study

      ea0022p861
    • Clinical and histopathologial characteristics of papillary thyroid microcarcinoma (PTMC)

      ea0022p862
    • The influence of radioiodine therapy in patient with non-toxic goiter with low RAIU in the enlarged nodule: a case report

      ea0022p863
    • HOMA index and waist circumference do not correlate with TSH levels in a group of euthyroid adults

      ea0022p864
    • The relation of the history of hypothyroidism with the risk for breast cancer: A review.

      ea0022p865
    • Selenium and pentoxifylline in patients with mild Graves' orbitopathy: Results of a randomized placebo-controlled double-blind clinical trial

      ea0022p866